amikacin has been researched along with tobramycin in 612 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 344 (56.21) | 18.7374 |
1990's | 63 (10.29) | 18.2507 |
2000's | 93 (15.20) | 29.6817 |
2010's | 88 (14.38) | 24.3611 |
2020's | 24 (3.92) | 2.80 |
Authors | Studies |
---|---|
Alborn, WE; Allen, NE; Kirst, HA; Toth, JE | 1 |
Cheng, ML; Duffield, J; Hu, C; Hwang, SB; Ichikawa, Y; Liang, CH; Marby, KA; Rabuka, D; Romero, A; Sears, P; Sgarbi, PW; Shue, YK; Sucheck, SJ; Yao, S | 1 |
Hines, JV; Means, JA | 1 |
Chaturvedi, AK; Shukla, PK; Singh, RV; Tandon, VK; Yadav, DB | 1 |
Avison, MB; Okazaki, A | 1 |
Baasov, T; Cherniavsky, M; Hainrichson, M; Nudelman, I; Shallom-Shezifi, D; Yaniv, O; Yaron, S | 1 |
Furuno, JP; Graffunder, E; Graves, J; Lodise, TP; Lomaestro, B; McGregor, JC; McNutt, LA; Miller, CD | 1 |
Adams, J; de Oliveira Garcia, D; Doi, Y; Paterson, DL | 1 |
El'Garch, F; Hocquet, D; Jeannot, K; Llanes-Barakat, C; Plésiat, P | 1 |
Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P | 1 |
Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV | 1 |
Chen, JH; Shen, GH; Wu, BD; Wu, KM | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
Ariza, J; Dominguez, MA; Gudiol, F; Guzmán, A; Peña, C; Pujol, M; Suarez, C; Tubau, F | 1 |
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
Courvalin, P; Galimand, M; Périchon, B | 1 |
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Bajolet, O; Berthelot, P; Bingen, E; Couetdic, G; Favre, R; Grattard, F; Hocquet, D; Husson, MO; Jeannot, K; Mariani-Kurkdjian, P; Marty, N; Plésiat, P; Roussel-Delvallez, M | 1 |
Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
Adams, JM; Doi, Y; Paterson, DL; Yamane, K | 1 |
Arakawa, Y; Ike, Y; Kimura, K; Kurokawa, H; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
Bertrand, X; Blanc, K; Hocquet, D; Monnet, DL; Muller, A; Plésiat, P; Talon, D | 1 |
Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Attree, I; Elsen, S; Jeannot, K; Köhler, T; Plésiat, P; van Delden, C | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Bratu, S; Georgescu, C; Landman, D; Martin, DA; Quale, J | 1 |
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE | 1 |
Berçot, B; Nordmann, P; Poirel, L | 1 |
Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Wickes, BW | 1 |
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD | 1 |
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
Gales, AC; Nordmann, P; Picão, RC; Poirel, L | 1 |
Attrée, I; Ducruix, A; El Garch, F; Llanes, C; Muller, C; Phan, G; Plésiat, P; Vettoretti, L | 1 |
Maurya, HK; Mishra, NN; Shukla, PK; Tandon, VK | 2 |
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Campbell, L; Church, DL; Gregson, DB; Laupland, KB; Pitout, JD | 1 |
Aboul-ela, F; Allam, K; Bodoor, K; Boisdore, M; Boyapati, V; Gopu, V; Miller, J; Treleaven, WD; Weldeghiorghis, T | 1 |
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
Acosta, J; Chaves, F; Juan, C; Oliver, A; Otero, JR; Sanz, F; Viedma, E; Zamorano, L | 1 |
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM | 1 |
Burns, JL; Dudley, MN; Griffith, DC; King, P; Lomovskaya, O | 1 |
Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
Giske, CG; Hermansen, NO; Leegaard, TM; Lia, A; Rajendra, Y; Ranheim, TE; Rydberg, J; Samuelsen, O; Sundsfjord, A; Toleman, MA; Walder, M; Walsh, TR | 1 |
Ge, Y; Juan, C; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Baussanne, I; Bussière, A; Décout, JL; Ennifar, E; Ganem-Elbaz, C; Halder, S; Mingeot-Leclercq, MP; Ouberai, M; Paris, JM; Riou, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP | 1 |
Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B | 1 |
Chow, JW; Frase, H; Smith, C; Toth, M; Vakulenko, SB | 1 |
Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
Kumar, R; Maurya, HK; Shukla, PK; Tandon, VK; Verma, MK | 1 |
Brown, JM; Gonoi, T; Ishikawa, J; Kogure, T; Mikami, Y; Shimada, R; Yazawa, K | 1 |
Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK | 1 |
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
Abele-Horn, M; Claus, H; Elias, J; Engelhardt, K; Frosch, M; Joseph, B; Oesterlein, A; Schoen, C; Turnwald, D; Valenza, G | 1 |
Blázquez, J; Couce, A; Rodríguez-Rojas, A | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Baussanne, I; Bussière, A; Décout, JL; Jolivalt, C; Mingeot-Leclercq, MP; Ouberai, M; Zimmermann, L | 1 |
Garneau-Tsodikova, S; Green, KD; Houghton, JL; Thamban Chandrika, N | 1 |
Fridman, M; Herzog, IM; Louzoun Zada, S | 1 |
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG | 1 |
Barros R S, V; Das, I; Décout, JL; Désiré, J; El Khoury, M; Mingeot-Leclercq, MP; Sautrey, G; Zimmermann, L | 1 |
Chen, CL; Deng, Y; Fyfe, C; Grossman, TH; Hunt, DK; Sun, C; Sutcliffe, JA; Xiao, XY | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D | 1 |
Briée, F; Décout, JL; Kempf, J; Mingeot-Leclercq, MP; Swain, J; Zimmermann, L | 1 |
Bera, S; Mondal, D | 1 |
Jiang, K; Lin, F; Wu, H; Xiao, J; Xiao, Z; Yan, X; Yu, J; Yue, Y; Zhao, M; Zhou, X | 1 |
Broughall, JM; Holt, HA; McCarthy, M; Reeves, DS | 1 |
Fu, KP; Neu, HC | 1 |
Dahlager, J; Milman, N | 1 |
Kondo, S; Takeuchi, T; Umezawa, H; Yagisawa, M | 1 |
Witchitz, JL | 1 |
Houang, ET; McKay-Ferguson, E | 1 |
Halter, J; Lewis, RP; Meyer, RD; White, M | 1 |
DeFuria, MD; Price, KE; Pursiano, TA | 1 |
Brumfitt, W; Hamilton-Miller, JM; Reyonolds, AV | 1 |
Beck, H; Freiesleben, H; Sack, K; Schulz, E; Züllich, B | 1 |
Gol'dberg, LE | 1 |
Abrutyn, E; Egert, J; Goodhart, GL; Root, RK; Watson, R | 1 |
Gallais, A | 1 |
Koperski, K; Schassan, HH; Scherf, H | 1 |
Davis, SD; Hyndiuk, RA; Sarff, LD | 3 |
Knothe, H; Krcméry, V | 1 |
Babić, I; Hajsig, D; Mostovac, D; Skalova, R | 1 |
Daschner, FD; Langmaack, H; Steffens, A | 1 |
Courtieu, AL; Drugeon, HB | 1 |
Hirai, CK; Takenaka, IM; Ximenes, J | 1 |
Hofherr, L; Meyer, M | 1 |
Gismondo, MR; Nicoletti, G; Russo, G; Toscano, MA | 1 |
Fields, BT | 1 |
Theopold, HM | 1 |
Arbeter, AM; Plotkin, SA | 1 |
Kohl, S; Pickering, LK | 1 |
Fieker, DH; McHenry, MC | 1 |
Blech, MF; Hartemann, P; Imbs, MA | 1 |
Kosakai, N; Oguri, T | 1 |
Hoogkamp-Korstanje, JA; Westerdaal, NA | 1 |
Moody, MR; Purvis, DS; Schimpff, SC; Wiernik, PH; Young, VM | 1 |
Carbon, C; Contrepois, A; Lamotte-Barrillon, S | 1 |
Maderazo, EG; Quintiliani, R; Seklecki, MM | 1 |
Jusko, WJ; Plaut, ME; Schentag, JJ | 1 |
Mandaleris, CD; Sande, MA; Strausbaugh, LJ | 1 |
Axline, SG; Pesanti, EL; Rhame, FS; Yu, VL | 1 |
Schimpff, SC | 1 |
Minshew, BH; Schoenknecht, FD; Swanzy, SR | 1 |
Brewer, NS | 1 |
Bettelheim, KA; Humble, MW | 1 |
Appel, GB; Neu, HC | 1 |
Moellering, RC; Murray, BE | 2 |
Gioannini, P | 1 |
Hopefl, AW | 1 |
Freiesleben, H; Henkel, W; Sack, K; Schulz, E; Züllich, B | 1 |
Guze, LB; Maitra, SK; Schotz, MC; Yoshikawa, TT | 1 |
Tsujimoto, T; Yama, H; Yamada, K | 1 |
Bartlett, M; Crane, JK; Griffin, PS; Miller, MA; Yousuf, M | 1 |
Courtieu, AL; Drugeon, HB; Maurisset, B | 1 |
Tsuchiya, T | 1 |
Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
Beert, J; Eyckmans, L | 1 |
Jones, PM; Jorgensen, JH; Lee, JC | 1 |
Candler, ER; Gangadharam, PR | 1 |
Altemeier, WA; Hummel, RP; Miskell, PW | 1 |
Minshew, BH; Pollock, HM; Schoenknecht, FD; Sherris, JC | 1 |
Keys, TF; Washington, JA | 1 |
Washington, JA; Yu, PK | 1 |
Ilstrup, DM; Kohner, PC; McCall, JT; Snyder, RJ; Washington, JA; Wiltse, CG | 1 |
Garretson, HD; Noonan, JD; Reid, KH; Shields, CB | 1 |
Winterbauer, RH | 1 |
Folb, PI | 1 |
Gearhart, P; Pickering, LK | 1 |
Lietman, PS; Lipsky, JJ; Smith, CR | 1 |
Barriere, SL; Conte, JE | 1 |
Follath, F; Spring, P; Vozeh, S; Wenk, M | 1 |
Gailliard, MC; Kazmierczak, A; Portier, H; Pothier, P; Siebor, E | 1 |
Cartier, F; Cormier, M; Dien, G; Guivarch, G; Hoel, JC | 1 |
Di Lena, C; Esposito, L; Marchi, K; Nobili, B; Pinto, L | 1 |
Berman, PA; Botha, P; Callanan, JJ; Elisha, G | 1 |
Brummett, RE | 1 |
Federspil, P; Schätzle, W; Tiesler, E | 2 |
Schassan, HH; Witt, U | 1 |
Gayer, J | 1 |
Moellering, RC | 1 |
Dzierzanowska, D | 2 |
Seligman, SJ | 1 |
Parry, MF | 1 |
Gorbach, SL; Mayhew, JW | 1 |
Agbayani, MM; Jhaveri, RC; Khan, AJ | 1 |
Bergan, T; Melby, K | 1 |
Dupont, C; Hammerberg, S; Marks, MI; Marks, S | 1 |
Bendrick, TW; Brummett, RE; Fox, KE; Himes, DL | 1 |
Jotzoff, M | 1 |
Block, CS; Fabian, B; Robinson, RG | 1 |
Lüthy, R | 2 |
Grunert, K; Kemmerich, B; Koeppe, P; Lode, H | 1 |
Ashby, CD; Lewis, JE; Nelson, JC | 1 |
Gregory, D; Hirschmann, JV | 1 |
Anhalt, JP; Brown, SD | 1 |
Federspil, P | 2 |
Flournoy, DJ | 1 |
Absolonová, V; Bohunová, Z; Krcméry, V; Zikmundová, V | 1 |
Anttila, M; Kangas, L; Kasanen, A; Nieminen, L; Sairio, E | 1 |
Kangas, L; Kasanen, A; Nieminen, AL; Nieminen, L; Sairio, E | 1 |
Habwe, V; Shadomy, S | 1 |
Kemmerich, B; Lode, H | 1 |
Schassan, HH | 1 |
McAllister, TA | 1 |
Cherubin, CE; Evans, HE; Hochstein, L; Khan, AJ | 1 |
Köhler, M; Naumann, P; Reintjens, E; Rosin, H | 1 |
Cohen, S; Kabins, SA; Nathan, C | 1 |
Greenstone, G; Hammerberg, S; Marks, MI; Silver, B | 1 |
Briedis, DJ; Robson, HG | 1 |
Linzenmeier, G; Naumann, P; Neussel, H; Rosin, H | 1 |
Knothe, H | 1 |
Acar, JF; Goldstein, F; Le Goffic, F; Talbot, JN; Witchitz, JL | 1 |
Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M | 1 |
Dhawan, V; Marso, E; Martin, WJ; Young, LS | 1 |
Mogyoros, M; Morgan, JR; Smith, JA | 1 |
Salstrom, SJ; Tan, JS | 1 |
Bodey, GP; Keating, MJ; Samaan, NA; Sethi, MR | 1 |
Kunz, LJ; Moellering, RC; Poitras, JW; Wennersten, C | 1 |
Mattina, R; Nicoletti, G; Pisano, A | 1 |
Ehret, JM; Eickhoff, TC | 1 |
Seneca, H | 1 |
Brummett, RE; Fox, KE | 1 |
Fishman, G; Meisels, H; Peyman, GA; Stainer, GA | 1 |
Dawkins, EJ; Geheber, CE; Kolb, LD; Stone, HH | 1 |
Sanders, CC; Wilson, SG | 1 |
Bismuth, R; Chardon, H; Cormier, M; Dublanchet, A; Duval, J; Fabiani, G; Mizon, F; Soussy, CJ | 1 |
Gleckman, R | 1 |
Drasar, FA; Farrell, W; Maskell, J; Williams, JD | 1 |
Blair, AD; Christopher, TG; Cutler, RE; Forrey, AW | 1 |
Arcieri, G; Miller, GH; Waitz, JA; Weinstein, MJ | 1 |
Kanazawa, Y; Kuramata, T | 1 |
Daneau, D; Klastersky, J | 1 |
Hewitt, WL; Stevens, P; Young, LS | 1 |
Stone, HH | 1 |
Kelly, MT; Matsen, JM | 1 |
Giamarellou, H; Xirouchaki, E | 1 |
Trese, MT; Winkler, BS | 1 |
Fennell, CL; LeBlanc, DJ; Lee, L; Tenover, FC | 1 |
Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Le Conte, P; Le Gallou, F; Lepage, JY; Potel, G; Raza, J | 1 |
Chiba, S; Kurata, Y; Yamamoto, M | 1 |
Bryant, RE; Fox, K; Morthland, VH; Oh, G | 1 |
Conrad, SA; King, JW; Todd, JR; White, MC | 1 |
Fausti, SA; Frey, RH; Henry, JA; McDonald, WJ; Olson, DJ; Schaffer, HI | 1 |
Cabezas, JA; Price, RG; Sanchez-Bernal, C; Vlitos, M | 1 |
Kelentey, BA; Kelentey, BJ | 1 |
Goodwin, SD; Heyd, A; Nix, DE; Wilton, JH | 1 |
Minneci, M; Nicoletti, G; Salmeri, M; Toscano, MA | 1 |
De Broe, ME; Verbist, L; Verpooten, GA | 1 |
Bayer, AS; Nast, CC; Norman, DC; Park, S; Speert, DP; Tu, J; Witt, M | 1 |
Davidson, RJ; Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
Fahrlender, RA; Muscato, JJ; Stout, JJ; Wilbur, DW | 1 |
Ismaeel, NA | 1 |
Gerding, DN; Hughes, RA; Larson, TA; Peterson, LR; Shanholtzer, C; Weiler, M | 1 |
Blaser, MJ; Hächler, H; Hare, RS; Jacoby, GA; Kayser, FH; Miller, GH; Santanam, P | 1 |
Bouvet, P; Buisson, Y; Driot, L; Ginot, L; Meyran, M; Schill, H; Tran Van Nhieu, G | 1 |
Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Fantin, B; Le Conte, P; Le Gallou, F; Lepage, JY; Potel, G; Raza, J | 1 |
Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Campochiaro, PA; Conway, BP | 1 |
Ansorg, R; Müller, KD; Wiora, J | 1 |
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
Binder, L; Breitfellner, G; Mittermayer, H; Riezinger, F; Rotter, M; Thiel, W; Watschinger, R | 1 |
Agueda, L; Bertrou, A; Chabanon, G; Henry, S; Marty, N | 1 |
Daikos, GL; Jackson, GG; Lolans, VT | 1 |
Kasuga, O; Matsushita, T; Yamaguchi, T | 1 |
Bittner, MJ; Destache, CJ; Hermann, KG; Meyer, SK | 1 |
Bakhache, P; Chivet, C; Douchain, F; Houdas, S; Lebas, L; Pautard, JC | 1 |
Murphy, JE | 1 |
Berger, SA; Dan, M; Gilad, A; Gorea, A; Krispin, M; Serour, F | 1 |
Menegus, MA; Petry, S; Yagupsky, P | 1 |
Brouzas, D; Grigoras, G; Kontogeorgos, G; Moschos, M; Panagakis, E; Zafiropoulos, N | 1 |
Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME | 1 |
Champlin, FR; Gibson, JA; Gilleland, HE; Gilleland, LB | 1 |
Crotchett, J; Fischer, RP; Miller-Crotchett, P; Reed, RL; Wu, AH | 1 |
Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
Livermore, DM; Said, AA | 1 |
Akalin, HE; Alacam, R; Torun, M | 1 |
Ishiguro, EE; Kusser, WC | 1 |
Ramírez-Ronda, CH; Saavedra, S; Vera, D | 1 |
Crosa, JH; Roberts, M; Tolmasky, ME; Woloj, M | 1 |
Guenounou, M; Migueres, ML; Ronco, E; Vacheron, F | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Legakis, NJ; Lymberopoulou, T; Velonaki, A; Velonakis, EM | 1 |
Giamarellou, H | 1 |
Hindler, J; Young, LS | 1 |
Gerding, DN; Larson, TA | 2 |
Gladen, HE | 1 |
Mayer, KH | 1 |
Bobadilla, M; Calva, JJ; Huazano, F; Ojeda, F; Ontiveros, C; Ponce de Leon, S; Ruiz-Palacios, GM; Sifuentes, J | 1 |
Boelaert, J; Glibert, B; Gordts, B; Van Landuyt, HW; Verbruggen, AM | 1 |
Belobraydic, KA; Flournoy, DJ; Qadri, SM | 1 |
Stratton, CW; Tausk, F; Weeks, LS | 1 |
Bailey, EJ; Chandrasekar, PH; Crane, LR | 1 |
Bailie, GR; Mathews, A | 1 |
Barry, AL; Cramer, C; Ferraresi, R; Hare, RS; Jones, RN; Lorber, RR; Miller, GH; Thornsberry, C | 1 |
Sahm, DF; Torres, C | 2 |
Hubrechts, JM; Nyssen, HJ; Roebben, E; Vanhoof, R | 1 |
Clark, RB; Hostetter, MK; Pakiz, CB; Sanders, CC | 1 |
Coude du Foresto, B; Courtieu, AL; Derriennic, M; Reynaud, AE | 1 |
Meyran, M; Thabaut, A | 1 |
Mizuno, A; Nakashima, M; Sato, R; Suzuki, Y; Uematsu, T; Yamazaki, T | 1 |
Gómez, JG; Jiménez-Cruz, JF; Tormo, FB | 1 |
Buisson, Y; Levagueresse, R; Meyran, M; Saliou, P; Santiago, M; Thabaut, A | 1 |
Caillon, J; Drugeon, HB; Juvin, ME; Pirault, JL | 1 |
Croydon, E; Weerts, D | 1 |
Desai, TK; Tsang, TK | 1 |
Delage, G; Desautels, L; Lamarre, A; Lapierre, JG; Lasalle, R; Legault, S; Masson, P; Spier, S | 1 |
Anfossi, G; Calcamuggi, G; Emanuelli, G; Lanzio, M; Marcarino, C | 1 |
Bair, JN; Bosso, JA; Marble, DA; Townsend, RJ; Zbrozek, AS | 1 |
Husson, MO; Izard, D; Leclerc, H | 2 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Arroyo, JC; Davis, J; Milligan, WL; Mitchell, D | 1 |
Couraud, L; Crockett, R; Fourtillan, JB; Leng, B; Saux, MC | 1 |
Crosa, JH; Roberts, MC; Tolmasky, ME; Woloj, M | 1 |
Meyer, RD | 1 |
McCracken, GH | 1 |
Bonetti, A; Luthy, R; Siegenthaler, WE | 1 |
Buring, J; Colton, T; Evans, DA; Hennekens, C; Mayrent, S; Rosner, B | 1 |
Jones, RN | 1 |
Bergeron, MG; Bergeron, Y | 1 |
Bergogne-Bérézin, E; Delcercq, D; Prokocimer, P; Serieys, C | 1 |
Lietman, PS; Moore, RD; Smith, CR | 4 |
Bruckner, DA; Hindler, JA | 1 |
Edson, RS; Terrell, CL | 1 |
Job, ML; Murphy, JE; Peltier, TT; Tointon, MM; Ward, ES | 1 |
Armstrong, DK; Dasta, JF | 1 |
Araujo, V; Bonet, M; Ferran, F; Gatell, JM; SanMiguel, JG; Soriano, E; Traserra, J | 1 |
Bianchi, L; Roncoroni, AJ | 1 |
Iyengar, BS; Kumar, V; Remers, WA; Wunz, TP | 1 |
Hale, DC; Matsen, JM; Saxon, B; Wright, DN | 1 |
Alessandria, E; Geraci, C; Nicoletti, G; Russo, G; Stefani, S; Toscano, MA | 1 |
De Broe, ME; Giuliano, RA; Verpooten, GA | 2 |
King, A; Phillips, I; Shannon, K | 1 |
Bengtsson, S; Bernander, S; Brorson, JE; Dornbusch, K; Forsgren, A; Hallander, H; Henning, C; Holm, S; Malmborg, AS; Nilsson, L | 1 |
Herva, E; Huovinen, P; Katila, ML; Klossner, ML; Renkonen, OV; Toivanen, P | 1 |
Garrett, CR; Gerding, DN; Larson, TA | 1 |
Nilsson, L; Sörén, L | 1 |
Elder, D; Hammerberg, O; Landis, S; Richardson, H | 1 |
Becker, A; Burdge, RE; Ellington, LL; Greenberg, RN; Perry, CR; Vossen, MK | 1 |
Makino, H; Mine, S; Sato, A; Tamachi, S; Tomioka, H; Yamaura, A | 1 |
Canawati, HN; Gilmore, DS; Graham, IE; Ibraham, MZ; Montgomerie, JZ; Morrow, JW | 1 |
Besse, MD; Crépy, A; Galizia, JP; Goldstein, P; Marson, JC; Pellerin, P | 1 |
Bouanchaud, DH; Rolin, O | 1 |
Bosso, JA; Marble, DA; Townsend, RJ | 1 |
Bovelacci, A; Montini, G; Ramacciotti, PG | 1 |
Cipriani, P; Focà, A; Geraci, C; Giordano, A; Stassi, G; Stefani, S; Varaldo, PE | 1 |
Sabath, LD; Tack, KJ | 1 |
DiVincenzo, CA; Venezio, FR | 1 |
Borges, LF; Chapman, PH | 1 |
Araujo, V; Ballesta, A; Castells, C; Elena, M; Gatell, JM; Jimenez de Anta, MT; Marin, JL; Moreno, A; SanMiguel, JG; Zamora, L | 1 |
Grassi, C | 1 |
Gerding, DN; Larson, TA; Peterson, LR | 1 |
Alvarez, S; Berk, SL; Holtsclaw-Berk, SA; Ortega, G; Verghese, A | 1 |
Allen, LV; Desai, SR; Rao, PS; Thompson, DF | 1 |
George, WJ; Insler, MS; Johnson, AP; LaCorte, WS; Woo, FL | 1 |
Maes, P | 1 |
Brion, N; Carbon, C; Contrepois, A; Delatour, F; Deybach, JC; Faurisson, F; Garaud, JJ; Levy, JC | 1 |
Caspers-Velu, L; D'Amico, DJ; Hanninen, LA; Kenyon, KR; Libert, J; Schrooyen, M; Shanks, E | 1 |
Hayasaka, S; Shiono, T | 1 |
Calia, FM; Greene, WH; Hornick, RB; Kluge, RM; Schimpff, SC; Standiford, HC; Tatem, B; Young, VM | 1 |
Hori, R; Inui, K; Kohno, M; Saito, H; Yamamoto, K | 1 |
Bryskier, A; Husson, MO; Izard, D; Leclerc, H; Vincent, P | 1 |
Heinert, G; Mondorf, W; Scherberich, J; Weber, W; Wyrobnik, J | 1 |
Falkiner, FR; Jacoby, GA; Keane, CT; McCann, SR | 1 |
Bricaire, F; Bure, A; Humbert, G; Vachon, F; Vilde, JL | 1 |
Murray, PR | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Daschner, FD; Schneider, H; Steffens, A | 1 |
Black, FO; Hawkins, JE; Johnsson, LG; Kingsley, TC; Matz, GJ | 1 |
Watanakunakorn, C | 1 |
Fleming, PJ; Hawkey, PM; Lewis, DA; Pitt, TL; Primavesi, RJ; Speller, DC | 1 |
Angehrn, P | 1 |
Cobbs, CG; Elliott, AM; Karam, GH | 1 |
Grönroos, P; Herva, E; Huovinen, P; Katila, ML; Klossner, ML; Renkonen, OV; Toivanen, P | 1 |
Lally, RT; Quall, CO; Woolfrey, BF | 1 |
Fillastre, JP; Godin, M; Hemet, J; Morin, JP; Olier, B; Tulkens, P; Viotte, G | 1 |
Fox, JM; Lally, RT; Quall, CO; Woolfrey, BF | 1 |
Ederer, MN; Lally, RT; Quall, CO; Woolfrey, BF | 1 |
Koornhof, HJ; Robinson, RG; Schrire, L | 1 |
DeTorres, OH; White, RE | 1 |
Sula, L; Sulová, J | 1 |
Kobayashi, Y; Ninomiya, T; Oyama, T | 1 |
Bourgault, AM; Gaudreau, C; Lamothe, F; Turgeon, F; Turgeon, P; Vincelette, J | 1 |
Barry, AL; Gavan, TL; Gerlach, EH; Jones, RN; Sommer, HM; Thornsberry, C | 1 |
Gutiérrez-Núñez, JJ; Nevárez, M; Ramírez-Ronda, CH; Reyes, Y | 1 |
Hale, DC; Jenkins, R; Matsen, JM | 1 |
Mirrett, S; Reimer, LG; Reller, LB | 1 |
Pickering, LK; Rutherford, I | 1 |
Buyssens, N; De Broe, ME; Paulus, GJ; Roels, F; Tulkens, PM; Van Hoof, F; Verpooten, GA; Wedeen, R | 1 |
Ryan, JA | 1 |
Lenoir, M; Marot, M; Uziel, A | 1 |
Araujo, V; Ballesta, A; Bohé, M; Bonet, M; Elena, M; Farré, M; Gatell, JM; Jimenez de Anta, MT; Marin, JL; San Miguel, JG; Zamora, L | 1 |
Sato, K | 1 |
Cross, AS; Kopecko, DJ; Opal, S | 1 |
Acar, J; Adam, D; Cadorniga, R; Dyas, A; Hallynck, T; Pijck, J; Soep, HH; Wenk, M; Wise, R | 1 |
Glew, RH; Pavuk, RA | 1 |
Dzierzanowska, D; Nowik-Jurek, M; Podleśny, J | 1 |
Ambrose, PJ; Harralson, AF; Tindula, RJ | 1 |
Gunter, JM; Gupta, VD; Stewart, KR | 1 |
Azanza Perea, JR; Cuena Boy, R; Echeverría Echepare, LM; Honorato Pérez, J | 1 |
Alegente, G; Marchi, B; Pieri, I; Progenie, G; Rubino, M; Saturni, A | 1 |
Cone, LA | 1 |
Jimenez, EM; Lindquist, LB; Montgomerie, JZ; Morrow, JW; Sapico, FL | 1 |
Gruensfelder, R; Kabins, SA; Nathan, C; Weinstein, RA | 1 |
Cherne, JE; Peterson, LR | 1 |
Knothe, H; Krcméry, V; Mitsuhashi, S | 1 |
Schmülling, RM; Ullmann, U | 1 |
Cox, HU; Luther, DG | 1 |
Juhlin, I; Tunevall, G | 1 |
Duncan, IB; Duncan, NH; Rennie, RP | 1 |
Fox, JM; Quall, CO; Woolfrey, BF | 1 |
Sanders, CC; Sanders, WE | 1 |
Ogawa, H; Osada, Y; Une, T | 1 |
Antal, M; Cervenka, J; Knothe, H; Krcméry, V; Lebek, G; Mitsuhashi, S; Seginková, Z | 1 |
Aberson, J; Thijm, HA; van der Waaij, D; Welling, GW | 1 |
Christe, M; Vaudaux, P; Waldvogel, FA | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Matzkowitz, AJ; Smith, RP; Sutphen, NT | 1 |
Burghoffer, B; Daguet, GL; Petit, JC; Richard, G | 1 |
Marks, MI; Scribner, RK; Tarpay, MM; Weber, AH; Welch, DF | 1 |
Matsumiya, H; Saito, A; Sato, K | 1 |
Baran, D; Klastersky, J; Levy, J | 1 |
Edson, RS; Keys, TF | 1 |
Armes, DA; Jones, P; L'Hommedieu, CS; Nelson, T; Nicholas, D; Pickering, LK | 1 |
Bauer, LA; Blouin, RA | 1 |
Descotes, J; Evreux, JC; Lievre, M; Ollagnier, M | 1 |
Akgün, Y; Akşit, F | 1 |
Baumueller, A; Frimodt-Møller, N; Hoyme, U; Lau, C; Madsen, PO; Maigaard, S; Nielsen, OS; Welling, PG | 1 |
Dupont, J; Fernández, A; Garay, G; López, H; Marcenac, F; Pavlovsky, S; Scaglione, C | 1 |
Farrar, WE; McGee, ZA; Rubens, CE | 1 |
Gammon, JA; Joseph, P; Schwab, I | 1 |
Casewell, M; Dacey, S; Datta, N; Hughes, V; Knight, S; Richards, H; Shannon, KP; Williams, G | 1 |
Al-Asadi, MJ; Greenwood, D; Towner, K | 1 |
Jolley, ME; Keegan, CL; Panas, HN; Schmidt, RL; Schwenzer, KS; Stroupe, SD; Wang, CH | 1 |
Granich, GG; Krogstad, DJ; Murray, PR; Pfaller, MA; Valdes, R | 1 |
Chiaradia, V; Crovatto, M; De Paoli, P; Grattoni, E; Ius, A; Santini, G | 1 |
Cafarelli, A; Cruciani, M; Magliulo, E; Piantieri, G | 1 |
Cortelezzi, A; Radaelli, F; Savarè, M | 1 |
Chmel, H; Eng, RH; Wolff, M | 1 |
Shah, PM; Siegel, K; Stille, W | 1 |
Daschner, F; Eiermann, T; Langmaack, H; Stark, GB | 1 |
Appleby, DH; John, JF | 1 |
Akalin, E; Baykal, M | 1 |
Beney, E; Blanc, PL; Robert, D; Tigaud, S; Vincent, P | 1 |
Godin, M; Morin, JP; Olier, B; Viotte, G | 1 |
Arpini, A; Bamonte, F; Marzanatti, M; Ongini, E; Parravicini, L | 1 |
Cheung, EY; Duncan, IB; Haldane, EV; Jackson, FL; McNaughton, RD; Morisset, RA; Noble, MA; Rennie, RP; Ronald, AR; Smith, JA | 1 |
McKnight, RP; Willis, JE | 1 |
Coppens, L; Klastersky, J; Mombelli, G; Thys, JP | 1 |
Luper, WE; Martin, RF; Phillips, LE; Rogers, TE | 1 |
DeTorres, OH | 1 |
Gorbach, SL; McGowan, K; Scheife, RT; Tally, FP | 1 |
Friesen, A; Hofstetter, A; Rothenberger, K; Streifinger, W | 1 |
Cuomo, V; Renna, G; Siro-Brigiani, G | 1 |
Aikawa, T; Ohtani, I; Ohtsuki, K; Omata, T; Ouchi, J; Saito, T; Sato, Y | 1 |
Aronoff, GR; Connors, BA; Evan, AP; Luft, FC | 1 |
Conzelman, GM; Franti, CE; Ling, GV; Ruby, AL | 1 |
Ferrari, FA; Marconi, M; Pagani, A; Siccardi, AG; Stefanoni, R | 1 |
Roy, I; Thadepalli, H | 1 |
Braveny, I; Machka, K; Voeckl, J | 1 |
DiPersio, JR; Krafczyk, TL | 1 |
Belohradsky, BH; Marget, W; Roos, R | 1 |
Legakis, NJ; Melissinos, K; Nicolas, KJ; Papavassiliou, J; Tselentis, J | 1 |
Gordon, LL; Hottendorf, GH | 1 |
Lee, YG | 1 |
Glotzbecker, C; Watanakunakorn, C | 1 |
Badal, RE; Baker, CN; Barry, AL; Jones, RN; Packer, RR; Thornsberry, C | 1 |
Kline, SS; Mauro, LS; Wolff, DJ | 1 |
Hirose, S; Inoue, T; Ito, K; Mano, K; Mita, S; Morita, Y; Sukoh, M; Takahashi, T; Togano, Y; Yamanaka, K | 1 |
Isaksson, B; Maller, R; Nilsson, LE; Nilsson, M | 1 |
Albertini, MT; Blanc, V; Davenas, C; Olleon, M; Peyret, M | 1 |
Garbincius, J; Jandreski, MA | 1 |
Matsuno, T; Shitara, T; Tsuchiya, T; Umemura, E | 1 |
Omri, A; Poisson, M; Ravaoarinoro, M | 1 |
Baquero, F; Culebras, E; Martínez, JL; Pérez-Díaz, JC | 1 |
Irby, NL; Sweeney, CR | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
Jarco, PE; Mitrzyk, B; Rybak, MJ | 1 |
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI | 1 |
Holt, HA; MacGowan, AP; Reeves, DS; White, LO | 1 |
Ategbo, S; Druon, D; Elian, JC; Farriaux, JP; Gottrand, F; Launay, V; Loeuille, GA; Turck, D; Vic, P | 1 |
Canis, F; Cavallo, JD; Husson, MO | 1 |
Bramlage, LR; Embertson, RM; Holcombe, SJ; Schneider, RK | 1 |
Itokazu, GS; Weinstein, RA | 1 |
Hostacká, A; Karelová, E | 1 |
Baron, D; Bugnon, D; Caillon, J; Drugeon, HB; Feigel, P; Kergueris, MF; Potel, G | 1 |
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
Li, RC; Ma, HH | 1 |
Abu-Hasan, N; Adwan, K; Al-Asmar, H | 1 |
Hostacká, A | 1 |
Hubbard, RW; Slocum, R | 1 |
Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
Fluit, AC; Schmitz, FJ; Verhoef, J | 1 |
Banerjee, SK; Dasgupta, A; Wells, A | 1 |
Hosino, K; Iwai, Y; Nakamura, A; Nakamura, S; O'Hara, K; Sawai, T; Seto, I | 1 |
Minami, S; Ogake, N; Takahata, M; Yamashiro, Y | 1 |
Forbes, B; Joynson, JA; Lambert, RJ | 1 |
Bedwell, DM; Keeling, KM | 1 |
Hanssen, AD; Khaliq, Y; Osmon, DR; Patel, R; Perry, AC; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
Hermida, J; Tutor, JC; Zaera, S | 1 |
Iyobe, S; Okubo, T | 1 |
Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
Adriensen, B; Husson, MO; Loiez, C; Massoni-Cristante, S | 1 |
Holzgrabe, U; Wienen, F | 1 |
Ciznár, I; Hostacká, A | 2 |
Chen, JG; Chen, XS; Lou, YL; Lü, JX; Lu, YS; Peng, Y | 1 |
Bertran, S; Gómez, E; Jiménez de Anta, MT; Julià, A; Ruiz, J; Sauca, G; Vila, J; Vila, X | 1 |
Abe, M; Araki, M; Horimi, T; Nasu, Y; Ono, N; Takahashi, I | 1 |
Devi, NA; Doss, VA; Parvathi, S; Raju, BA | 1 |
Chen, SH; Chou, CA; Ko, JY; Lin, SJ; Yeh, HH | 1 |
Bajer, AA; Lorson, CL; Mattis, V; Wolstencroft, EC; Young, PJ | 1 |
Kaye, D; Levison, ME | 1 |
Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
van der Bijl, P | 1 |
Kedzia, WB; Mirska, I | 1 |
Cheung, PY; Etches, PC; Peliowski, A; Robertson, CM; Tyebkhan, JM | 1 |
Chen, X; Kong, HS; Li, XF; Wang, JF; Wu, MJ; Yang, Q | 1 |
Zagólski, O | 1 |
Hermida, J; Tutor, JC | 1 |
Bossuyt, X; Godding, V; Leal, T; Lebecque, P; Reychler, G; Zylberberg, K | 1 |
Day, AS; Lue, JH; Yang, TH; Young, YH | 1 |
Udou, T | 1 |
Buszman, E; Trzcionka, J; Wrześniok, D | 1 |
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
Bookstaver, PB; Johnson, JW; McCoy, TP; Stewart, D; Williamson, JC | 1 |
Pacifici, GM | 1 |
Fu, GN; Gan, WE; He, YZ; Xie, HY; Yu, CZ | 1 |
Cho, DT; Kang, HY; Kim, J; Lee, JC; Lee, YC; Seol, SY | 1 |
Costa, JG; Coutinho, HD; Falcão-Silva, VS; Lima, EO; Siqueira-Júnior, JP | 1 |
Boucher, BA; Croce, MA; Czosnowski, QA; Fabian, TC; Magnotti, LJ; Swanson, JM; Wood, GC | 1 |
Gill, RT; Struble, JM | 1 |
Goldstein, SL; Hyder, A; Moffett, BS; Zappitelli, M | 1 |
Bratt, GW; Dille, MF; Fausti, SA; Gallun, F; Gordon, JS; Helt, WJ; Konrad-Martin, D; Reavis, KM | 1 |
Borsiczky, B; Cseh, G; Frank, D; Kocsis, B; Miseta, A; Nagy, T; Tokés-Füzesi, M | 1 |
Burd, EM; Ribner, BS; Shak, JR; Whitaker, JA | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Appelbaum, PC; Beachel, L; Clark, C; Credito, K; Kosowska-Shick, K; McGhee, P; Pankuch, GA | 1 |
Cox, ZL; McCoy, JA; Nelsen, CL; Peterson, JF; Waitman, LR | 1 |
Liborio, AB | 1 |
Cuteri, V; Jesudasen, N; Kaliamurthy, J; Preziuso, S; Salman, A; Thomas, PA | 1 |
Anan, N; Ito, A; Nakamura, R; Toba, S; Tsuji, M | 1 |
Koh, JW; Park, JH; Song, NH | 1 |
Asseray, N; Bugnon, D; Caillon, J; Dubé, L; Jacqueline, C; Potel, G | 1 |
Adam, H; Findlay, B; Gin, AS; Hoban, DJ; Karlowsky, JA; Lawson, CD; Lynch, JP; Rubinstein, E; Schweizer, F; Walkty, A; Zelenitsky, S; Zhanel, GG | 1 |
Goyal, S; Warner, DB | 1 |
Hewer, SL | 1 |
Fraud, S; Gilmour, C; Kerr, N; Krahn, T; Lau, CH; Poole, K; Tilak, J | 1 |
Argyropoulou, A; Chrysouli, Z; Daikos, GL; Galani, I; Giamarellou, H; Panagea, T; Petrikkos, G; Plakias, G; Poulakou, G; Psichogiou, M; Souli, M; Stefanou, I | 1 |
Banerjee, D; Srinivasan, A; Syal, K | 1 |
Jahnke, N; Remmington, T; Ryan, G | 1 |
Choi, JY; Kim, JM; Ku, NS; Lee, K; Yong, D | 1 |
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
Biswas, T; Chen, W; Garneau-Tsodikova, S; Houghton, JL; Tsodikov, OV | 1 |
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
Goss, CH; Quon, BS; Ramsey, BW | 1 |
Prescott, WA | 1 |
Fiel, SB | 1 |
Aguilar, B; Fair, RJ; Hensler, ME; McCoy, LS; Nizet, V; Tor, Y | 1 |
Böttger, EC; Freihofer, P; Lenaerts, A; Meyer, M; Scherman, M; Teague, J | 1 |
Edwards, JD; Wargo, KA | 1 |
Aganj, M; Ali, L; Sakinc, T; Shokoohizadeh, L; Soleimani, N | 1 |
Burton, ME; Johnson, PN; Miller, JL; Miller, MM | 1 |
Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
Boiano, JM; Steege, AL; Sweeney, MH; Tsai, RJ | 1 |
Chang, SC; Ho, MW; Hseuh, PR; Lee, CH; Liu, JW; Liu, JY; Sheng, WH; Wang, FD; Wang, JT | 1 |
Al-Mohtaseb, Z; Amescua, G; Aziz, H; Garcia, N; Pantanelli, SM; Patel, R; Sise, A | 1 |
Beaudoin, T; LiPuma, JJ; Tom, SK; Waters, V; Yau, YC | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Ahangarzadeh Rezaee, M; Ghotaslou, R; Goli, HR; Hasani, A; Rahmati-Yamchi, M; Sheikhalizadeh, V | 2 |
Bojkova, SA; Poliakova, EM | 1 |
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ | 1 |
Alkroud, A; Cheng, S; Churilla, BM; Churilla, TM; Clancy, CJ; Doi, Y; Haidar, G; Nguyen, MH; Shields, RK | 1 |
Holzgrabe, U; Schmitt, S; Wienen, F | 1 |
Akhi, MT; Asgharzadeh, M; Ghotaslou, R; Mohammadzadeh Asl, Y; Yeganeh Sefidan, F | 1 |
Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS | 1 |
Coenye, T; Crabbé, A; Davis, R; De La Fuente-Nùñez, C; Hancock, RE; Ledesma, MA; Liu, Y; Matthijs, N; Nickerson, CA; Rigole, P; Sarker, S; Van Houdt, R | 1 |
Culbertson, WW; Shah, P; Zhu, D | 1 |
Alfonso, EC; Gibbons, A; Miller, D; OʼBrien, TP; Palioura, S; Spierer, O | 1 |
Deborska-Materkowska, D; Durlik, M; Kawecki, D; Mlynarczyk, A; Mlynarczyk, G; Pacholczyk, M; Paczek, L; Szymanek-Majchrzak, K | 1 |
Britton, WJ; Chan, HK; Chang, RYK; Kutter, E; Lin, Y; Morales, S | 1 |
Charbek, E; Rowbotham, NJ; Smith, S | 1 |
Almeida, LG; Cassu-Corsi, D; Gales, AC; Martins, WM; Nicoletti, AG; Vasconcelos, AT | 1 |
Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C | 1 |
Marsot, A; Pasche, V; Thirion, DJG | 1 |
Bilton, D; Cipolli, M; Clancy, JP; Eagle, G; Fajac, I; Galeva, I; Gupta, R; Konstan, MW; Liu, K; McGinnis, JP; Minic, P; Pressler, T; Quittner, AL; Sands, D; Solé, A | 1 |
Mahmood, I | 1 |
Burt, RA; Lockhart, PJ; Ogier, JM | 1 |
Chen, C; Cui, Y; Lei, L; Li, M; Luo, D; Ma, L; Zhai, X; Zhou, Y | 1 |
Burgess, DS; Clark, JA; Kulengowski, B | 1 |
Ali, HB; Asuman, B; Kubra, HU; Sarah, AF; Sreylis, N; Yeliz, TC | 1 |
Bostrom, MP; Carli, AV; Levack, AE; Miller, AO; Turajane, K; Wellman, DS; Yang, X | 1 |
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
Arya, DP; Bassenden, AV; Berghuis, AM; Blanchet, J; Dumalo, L; Maiti, K; Park, J | 1 |
Bostrom, MP; Carli, AV; Driscoll, DA; Levack, AE; Miller, AO; Turajane, K; Wellman, DS; Yang, X | 1 |
Capalash, N; Kashyap, S; Sharma, P | 1 |
Duong, A; Marsot, A; Simard, C; Thirion, DJG; Williamson, D | 1 |
Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C | 1 |
Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN | 1 |
Bakkaloglu, Z; Demirbas, Z; Dizbay, M; Ozger, HS; Suzuk-Yildiz, S | 1 |
Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
de Dios, R; Gadar, K; McCarthy, RR | 1 |
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
Baniasadi, S; Hassanzad, M; Kouhestani, F | 1 |
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
Huang, Y; Liu, H; Lu, W; Peng, J; Qin, G; Wu, D; Xiao, J | 1 |
Hall, RM; Harmer, CJ; Nigro, SJ | 1 |
Beigverdi, R; Emaneini, M; Halimi, S; Jabalameli, F; Siroosi, M | 1 |
36 review(s) available for amikacin and tobramycin
Article | Year |
---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Recent advances in antimicrobial therapy.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Humans; Metronidazole; Sisomicin; Spectinomycin; Sulfamethoxazole; Ticarcillin; Tobramycin; Trimethoprim | 1977 |
Newer antibacterial and antimycotic drugs. Critical appraisal.
Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Clindamycin; Flucytosine; Humans; Imidazoles; Penicillins; Rifampin; Spectinomycin; Sulfamethoxazole; Tetracyclines; Tobramycin; Trimethoprim | 1978 |
[Serratia, cause of nosocomial infections and its occurrence in the patient's environment (author's transl)].
Topics: Air Microbiology; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Epidemiologic Methods; Erythromycin; Gentamicins; Humans; Lincomycin; Polymyxins; Serratia marcescens; Sisomicin; Soil Microbiology; Tetracyclines; Tobramycin; Water Microbiology | 1979 |
Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Interactions; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Streptomycin; Tobramycin | 1977 |
Gentamicin in 1978.
Topics: Amikacin; Animals; Bacterial Infections; Drug Synergism; Ear Diseases; Gentamicins; Humans; Kidney; Kidney Diseases; Netilmicin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Sisomicin; Tobramycin; Urinary Tract Infections | 1978 |
Patterns and mechanisms of antibiotic resistance.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cell Membrane Permeability; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Genetics, Microbial; Gentamicins; Humans; Penicillin Resistance; R Factors; Salmonella; Shigella; Staphylococcus aureus; Tobramycin; Translocation, Genetic | 1978 |
[Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Sisomicin; Streptomycin; Tobramycin | 1978 |
Empiric therapy of febrile granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin | 1979 |
Determination of aminoglycoside antibiotics in biological fluids: a review.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Biological Assay; Chromatography, Gas; Chromatography, High Pressure Liquid; Gentamicins; Humans; Isotope Labeling; Kanamycin; Mass Spectrometry; Radioimmunoassay; Structure-Activity Relationship; Tobramycin | 1979 |
Deoxygenation of aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Kanamycin; Molecular Conformation; Structure-Activity Relationship; Tobramycin | 1979 |
Recent advances in antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Flucytosine; Gentamicins; Metronidazole; Penicillins; Plasmids; Sisomicin; Tobramycin | 1976 |
[Aminoglycoside antibiotics from clinical viewpoint].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Glomerular Filtration Rate; Kanamycin; Klebsiella Infections; Proteus Infections; Providencia; Pseudomonas Infections; Serratia; Sisomicin; Streptomycin; Tobramycin | 1975 |
[Measuring the excretion of aminoglycosides into the saliva].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Gentamicins; Rabbits; Saliva; Sisomicin; Tobramycin | 1991 |
Aminoglycosides: another look at current and future roles in antimicrobial therapy.
Topics: Amikacin; Drug Resistance, Microbial; Forecasting; Gentamicins; Humans; Tobramycin | 1990 |
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1986 |
Review of epidemic aminoglycoside resistance worldwide.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Gentamicins; Humans; Klebsiella; Pseudomonas aeruginosa; R Factors; Tobramycin | 1986 |
Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.
Topics: Amikacin; Aminoglycosides; Cost-Benefit Analysis; Ear Diseases; Gentamicins; Humans; Kidney Diseases; Netilmicin; Tobramycin | 1987 |
Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Gentamicins; Glomerular Filtration Rate; Humans; Kidney; Netilmicin; Random Allocation; Risk; Time Factors; Tobramycin | 1986 |
Aminoglycoside toxicity in infants and children.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Child; Clinical Trials as Topic; Evoked Potentials, Auditory; Gentamicins; Hearing; Humans; Infant; Infant, Newborn; Kanamycin; Kidney; Prospective Studies; Risk; Streptomycin; Tobramycin; Vestibule, Labyrinth | 1986 |
Aminoglycoside antibiotics in infectious diseases. An overview.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kanamycin; Kinetics; Neomycin; Netilmicin; Pneumonia; Sepsis; Sisomicin; Streptomycin; Tobramycin | 1986 |
In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrations.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kanamycin; Lactams; Microbial Sensitivity Tests; Tobramycin | 1986 |
Shunt infections: prevention and treatment.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Injections, Intraventricular; Klebsiella Infections; Leukocytes; Meningitis; Premedication; Pseudomonas Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
Respiratory infections: clinical evaluation.
Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin | 1985 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Clinical pharmacokinetics of aminoglycosides in the neonate: a review.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Birth Weight; Drug Administration Schedule; Gentamicins; Humans; Infant, Newborn; Netilmicin; Tobramycin | 2009 |
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 2012 |
Inhaled antibiotics in cystic fibrosis: what's new?
Topics: Administration, Inhalation; Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Child, Preschool; Ciprofloxacin; Clinical Trials, Phase III as Topic; Cystic Fibrosis; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Rate; Tobramycin; Treatment Outcome | 2012 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2012 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Child; Cystic Fibrosis; Disease Progression; Gentamicins; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2013 |
Inhaled antibiotics for lower airway infections.
Topics: Administration, Inhalation; Amikacin; Amphotericin B; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Colistin; Cystic Fibrosis; Gentamicins; Humans; Nebulizers and Vaporizers; Respiratory Tract Infections; Tobramycin | 2014 |
Aerosolized antibiotics in cystic fibrosis: an update.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Equipment Design; Humans; Levofloxacin; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Aminoglycoside-induced nephrotoxicity.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Kidney Diseases; Tobramycin | 2014 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Forced Expiratory Volume; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2018 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
34 trial(s) available for amikacin and tobramycin
Article | Year |
---|---|
Therapy of infection in patients with granulocytopenia.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Blood Transfusion; Carbenicillin; Cephalothin; Clinical Trials as Topic; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Infections; Kidney; Leukocyte Count; Mycoses; Neoplasms; Pseudomonas Infections; Ticarcillin; Tobramycin | 1977 |
[Evaluation of current aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Clinical Trials as Topic; Drug Evaluation; Drug Resistance, Microbial; Gentamicins; Humans; Sisomicin; Tobramycin | 1979 |
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1977 |
Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalothin; Drug Therapy, Combination; Gentamicins; Hearing Disorders; Humans; Kidney Diseases; Middle Aged; Tobramycin | 1979 |
Evaluation of three antibiotic programs in newborn infants.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bilirubin; Cephalothin; Drug Therapy, Combination; Evaluation Studies as Topic; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pneumonia; Sepsis; Tobramycin | 1978 |
[Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Female; Gentamicins; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Kinetics; Male; Middle Aged; Sisomicin; Tobramycin | 1978 |
Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefazolin; Cephalothin; Gentamicins; Humans; Male; Ticarcillin; Tobramycin | 1977 |
Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.
Topics: Amikacin; Drug Administration Schedule; Female; Humans; Kidney Cortex; Kidney Neoplasms; Male; Microscopy, Electron; Nephrectomy; Tobramycin | 1991 |
Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Cost-Benefit Analysis; Female; Gentamicins; Gram-Negative Bacteria; Humans; Length of Stay; Male; Monitoring, Physiologic; Prospective Studies; Tobramycin | 1990 |
Penetration of aminoglycosides into human peritoneal tissue.
Topics: Amikacin; Female; Humans; Infusions, Intravenous; Male; Netilmicin; Peritoneum; Random Allocation; Tobramycin | 1990 |
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
Aminoglycoside resistance: a worldwide perspective.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Kidney; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1986 |
Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.
Topics: Amikacin; Aminoglycosides; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Serratia; Tobramycin; United States | 1986 |
European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; beta-Lactamase Inhibitors; Child; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Netilmicin; Neutropenia; Penicillins; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1987 |
Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Gentamicins; Glomerular Filtration Rate; Humans; Kidney; Netilmicin; Random Allocation; Risk; Time Factors; Tobramycin | 1986 |
Aminoglycoside toxicity in infants and children.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Child; Clinical Trials as Topic; Evoked Potentials, Auditory; Gentamicins; Hearing; Humans; Infant; Infant, Newborn; Kanamycin; Kidney; Prospective Studies; Risk; Streptomycin; Tobramycin; Vestibule, Labyrinth | 1986 |
Qualitative overview of randomized trials of aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Gentamicins; Hearing; Humans; Kidney; Netilmicin; Random Allocation; Risk; Sisomicin; Tobramycin | 1986 |
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Female; Gentamicins; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Tobramycin | 1987 |
Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.
Topics: Amikacin; Hearing Disorders; Humans; Netilmicin; Regression Analysis; Risk Factors; Sex Factors; Time Factors; Tobramycin | 1987 |
Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
Topics: Adult; Aged; Amikacin; beta 2-Microglobulin; Clinical Trials as Topic; Creatinine; Humans; Kanamycin; Kidney Diseases; Middle Aged; Prospective Studies; Random Allocation; Tobramycin | 1985 |
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Female; Gentamicins; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia; Tobramycin | 1984 |
Early effects of gentamicin, tobramycin, and amikacin on the human kidney.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Female; Gentamicins; Histocytochemistry; Humans; Kidney; Kidney Tubules, Distal; Kinetics; Male; Middle Aged; Tobramycin | 1984 |
Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Auditory Threshold; Creatinine; Ear; Female; Humans; Kanamycin; Kidney; Male; Middle Aged; Tobramycin | 1983 |
Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study.
Topics: Amikacin; Bacteria; Gentamicins; Half-Life; Humans; Kanamycin; Kinetics; Microbial Sensitivity Tests; Tobramycin | 1983 |
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
Topics: Amikacin; Body Temperature; Female; Gentamicins; Hearing Loss; Humans; Kanamycin; Male; Probability; Risk; Sepsis; Statistics as Topic; Time Factors; Tobramycin | 1984 |
A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Gentamicins; Humans; Netilmicin; Prospective Studies; Tobramycin | 1982 |
Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Humans; Injections, Intramuscular; Kanamycin; Proteus Infections; Providencia; Pseudomonas Infections; Random Allocation; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1980 |
Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Kanamycin; Kinetics; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1982 |
Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
Topics: Aerobiosis; Amikacin; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Clindamycin; Costs and Cost Analysis; Gentamicins; Humans; Tobramycin | 1981 |
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sulbactam; Tobramycin | 1994 |
Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anthropometry; Body Composition; Ceftazidime; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Nutritional Status; Opportunistic Infections; Prospective Studies; Pseudomonas Infections; Tobramycin | 1997 |
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
Topics: Amikacin; Aminoglycosides; Anti-Infective Agents; Audiometry, Pure-Tone; Auditory Threshold; Diuretics; Ethacrynic Acid; Female; Furosemide; Gentamicins; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Male; Pancuronium; Respiratory Insufficiency; Severity of Illness Index; Tobramycin; Vancomycin; Vecuronium Bromide | 2006 |
Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin.
Topics: Adult; Aged; Amikacin; Decision Support Systems, Clinical; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Tobramycin | 2011 |
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Topics: Administration, Inhalation; Adult; Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Liposomes; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Surveys and Questionnaires; Symptom Assessment; Symptom Flare Up; Tobramycin; Treatment Outcome | 2020 |
544 other study(ies) available for amikacin and tobramycin
Article | Year |
---|---|
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biological Transport; Escherichia coli; Indicators and Reagents; Kinetics; Structure-Activity Relationship | 1987 |
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Structure-Activity Relationship | 2005 |
Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.
Topics: Aminoglycosides; Bacterial Proteins; Fluorescence Resonance Energy Transfer; RNA-Binding Proteins; RNA, Bacterial; T-Box Domain Proteins | 2005 |
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Methyl Ethers; Molecular Structure; Naphthoquinones | 2005 |
Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Butirosin Sulfate; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Kanamycin; Kanamycin Kinase; Microbial Sensitivity Tests; Mutation; Neomycin; Stenotrophomonas maltophilia | 2007 |
Overexpression and initial characterization of the chromosomal aminoglycoside 3'-O-phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa.
Topics: Bacterial Proteins; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Kanamycin Kinase; Kinetics; Phosphorylation; Pseudomonas aeruginosa | 2007 |
Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Risk; Risk Factors | 2007 |
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
Topics: Amino Acid Sequence; Aminoglycosides; beta-Lactamases; Brazil; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biological Evolution; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gene Silencing; Genes, Bacterial; Microbial Sensitivity Tests; Mutagenesis, Insertional; Mutation; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2007 |
In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Capreomycin; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Nontuberculous Mycobacteria | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Endemic Diseases; Female; Gastrointestinal Tract; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Pharynx; Pseudomonas aeruginosa; Pseudomonas Infections; Rectum; Risk Factors | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; North America; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2007 |
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Protein Binding; Ribosome Subunits, Small; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cefepime; Cephalosporins; Culture Media; Drug Resistance, Multiple; Fluoroquinolones; France; Hospitals, University; Humans; Incidence; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Ciprofloxacin; DNA Primers; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Molecular Sequence Data; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors; Virulence | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Endemic Diseases; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; New York City; Sequence Analysis, DNA | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
Topics: Anti-Bacterial Agents; beta-Lactamases; Enterobacter cloacae; Female; Humans; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Pseudomonas putida; RNA, Ribosomal, 16S | 2009 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Ceftriaxone; Clindamycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Cystic Fibrosis; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum | 2009 |
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Fungi; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur | 2009 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Fluoroquinolones; Humans; Travel | 2009 |
Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Topics: Binding Sites; Chemistry, Physical; Databases, Factual; Drug Design; Ligands; Magnetic Resonance Spectroscopy; Molecular Weight; Organic Chemicals; Quality Control; RNA; Small Molecule Libraries | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Cross Infection; Humans; Molecular Sequence Data; Pseudomonas aeruginosa | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure | 2009 |
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
Topics: Aerosols; Anti-Bacterial Agents; Bacteria; Biofilms; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Cystic Fibrosis; Humans; Levofloxacin; Lung Diseases; Microbial Sensitivity Tests; Ofloxacin; Sputum | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion.
Topics: Alleles; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Norway; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping; Sweden | 2010 |
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
Topics: Anti-Bacterial Agents; Calorimetry; Framycetin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors | 2010 |
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2010 |
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
Topics: Aged; Amikacin; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Directed Molecular Evolution; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis; Mutation; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Green Chemistry Technology; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur; Water | 2010 |
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Base Sequence; Canada; Cattle; DNA Primers; Drug Resistance, Bacterial; Female; Genes, Bacterial; Homozygote; In Vitro Techniques; Mastitis, Bovine; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 16S | 2010 |
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Drug Resistance, Bacterial; Germany; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fosfomycin; Mutation; Pseudomonas aeruginosa | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
Topics: Antifungal Agents; Candida; Catalysis; Drug Evaluation, Preclinical; Micelles; Microbial Sensitivity Tests; Naphthoquinones; Oxygen; Sporothrix; Trichophyton; Water | 2011 |
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Framycetin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Naphthalenes; Staphylococcus aureus; Structure-Activity Relationship | 2013 |
Synthesis and Biological Activity of Mono- and Di-N-acylated Aminoglycosides.
Topics: | 2015 |
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
Topics: Aminoglycosides; Anti-Bacterial Agents; Escherichia coli Proteins; Framycetin; Gram-Negative Bacteria; Kanamycin; Microbial Sensitivity Tests; Ribose; Structure-Activity Relationship; Trisaccharides | 2016 |
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2016 |
New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Framycetin; Glucosamine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Surface-Active Agents | 2016 |
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Halogenation; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrrolidinones; Tetracycline Resistance; Tetracyclines | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship | 2017 |
Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Eukaryotic Cells; Framycetin; Humans; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship; Surface-Active Agents | 2018 |
Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pseudomonas aeruginosa; Quorum Sensing; Structure-Activity Relationship | 2020 |
Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Biotransformation; Carbenicillin; Drug Interactions; Gentamicins; Humans; Hydrogen-Ion Concentration; Penicillins; Ticarcillin; Tobramycin | 1976 |
In vitro study of netilmicin compared with other aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin; Staphylococcus aureus; Tobramycin | 1976 |
The pH-dependent influence of aminoglycoside antibiotics on iodohippurate accumulation in rabbit renal cortical slices.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Gentamicins; Hydrogen-Ion Concentration; In Vitro Techniques; Iodohippuric Acid; Kanamycin; Kidney Cortex; Rabbits; Streptomycin; Tobramycin | 1978 |
Aminoglycoside 6'-N-acetyl-transferase of Pseudomonas aeruginosa: structural requirements of substrate.
Topics: Acetylation; Acetyltransferases; Amikacin; Aminoglycosides; Butirosin Sulfate; Chemical Phenomena; Chemistry; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Neomycin; Pseudomonas aeruginosa; Ribostamycin; Tobramycin | 1975 |
[Mechanisms of inactivation of aminosides. Relationship to phenotype in Gram negative bacilli].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Butirosin Sulfate; Drug Resistance, Microbial; Enterobacteriaceae; Framycetin; Gentamicins; Kanamycin; Paromomycin; Phenotype; R Factors; Sisomicin; Structure-Activity Relationship; Tobramycin | 1975 |
Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Pseudomonas; Tobramycin | 1976 |
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
Topics: Amikacin; Aminoglycosides; California; Carbenicillin; Cross Infection; Enterobacteriaceae Infections; Gentamicins; Hospitals, General; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Sisomicin; Tobramycin | 1976 |
Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
Topics: Acinetobacter; Alcaligenes; Amikacin; Bacteria; Butirosin Sulfate; Dibekacin; Drug Resistance, Microbial; Enterobacteriaceae; Flavobacterium; Gentamicins; Kanamycin; Neomycin; Paromomycin; Pseudomonas; Ribostamycin; Staphylococcus; Tobramycin | 1976 |
In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Butirosin Sulfate; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Neomycin; Paromomycin; Pseudomonas aeruginosa; Ribostamycin; Sisomicin; Streptomycin; Tobramycin | 1976 |
[Side effects of aminoglycosides: nephrotoxicity (author's transl)].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Butirosin Sulfate; Creatinine; Dose-Response Relationship, Drug; Female; Gentamicins; Guinea Pigs; Humans; Kanamycin; Kidney Tubules; L-Lactate Dehydrogenase; Rats; Sisomicin; Tobramycin | 1976 |
[New aminoglycoside desoxystreptamine-containing antibiotics].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Butirosin Sulfate; Drug Resistance, Microbial; Gentamicins; Hexosamines; Lethal Dose 50; Microbial Sensitivity Tests; Molecular Conformation; Paromomycin; Ribostamycin; Sisomicin; Tobramycin | 1976 |
Community-acquired Acinetobacter calcoaceticus var anitratus pneumonia.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Alcoholism; Amikacin; Diagnostic Errors; Drug Resistance, Microbial; Female; Gentamicins; Humans; Liver Cirrhosis; Male; Middle Aged; Minocycline; Pneumonia; Sputum; Staining and Labeling; Tobramycin | 1977 |
Comparative study of the influence of aminoglycoside antibiotics on the activity of the horizontal semicircular canal in the frog.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Anura; Dihydrostreptomycin Sulfate; Hydrogen-Ion Concentration; Paromomycin; Penicillins; Saline Solution, Hypertonic; Semicircular Canals; Sisomicin; Streptomycin; Tobramycin | 1979 |
Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
Topics: Amikacin; Bacteria; Carbenicillin; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1978 |
Bacteriologic cure of experimental Pseudomonas keratitis.
Topics: Administration, Topical; Amikacin; Animals; Carbenicillin; Drug Evaluation; Guinea Pigs; Keratitis; Male; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1978 |
Therapeutic effect of topical antibiotic on untreated eye in experimental keratitis.
Topics: Absorption; Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Biological Availability; Cornea; Drug Evaluation, Preclinical; Guinea Pigs; Kanamycin; Keratitis; Male; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Tobramycin | 1978 |
Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
Topics: Amikacin; Drug Resistance, Microbial; Gentamicins; Kanamycin; Lysogeny; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1979 |
[Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Kanamycin; Proteus mirabilis; Pseudomonas aeruginosa; Sisomicin; Staphylococcus aureus; Tobramycin | 1978 |
In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Topics: Amikacin; Aminoglycosides; Azlocillin; Drug Synergism; Escherichia coli; Gentamicins; Imidazolidines; Klebsiella pneumoniae; Netilmicin; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1979 |
[Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Escherichia coli; Gentamicins; Kanamycin; Kinetics; Klebsiella; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia; Tobramycin | 1979 |
Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Drug Synergism; Gentamicins; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1979 |
A broth-disc technique for the assay of antibiotic synergism.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Drug Synergism; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus; Tobramycin | 1979 |
[Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
Topics: Amikacin; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Proteus; Pseudomonas aeruginosa; Serratia; Sisomicin; Tobramycin | 1979 |
The new aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Gentamicins; Microbial Sensitivity Tests; Tobramycin | 1976 |
[Animal experiments concerning the neurotoxicity of aminoglycosid antibiotics. Electron microscopic findings regarding dose--depending mitochondrial damage in the cochlear nucleus of the guinea pig (author's transl)].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cochlear Nerve; Gentamicins; Guinea Pigs; Kanamycin; Mitochondria; Nerve Degeneration; Tobramycin | 1976 |
New antibiotics and old diseases.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Humans; Penicillin Resistance; Spectinomycin; Sulfonamides; Tobramycin; Trimethoprim | 1977 |
[Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
Topics: Amikacin; Enterobacteriaceae; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Proteus; Pseudomonas aeruginosa; Serratia; Staphylococcus; Streptococcus; Streptococcus pneumoniae; Tobramycin | 1975 |
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Topics: Amikacin; Aminoglycosides; Ampicillin; Carbenicillin; Cephalothin; Child; Colistin; Cystic Fibrosis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Sputum; Tobramycin | 1979 |
In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Carbenicillin; Gentamicins; Humans; Microbial Sensitivity Tests; Neoplasms; Netilmicin; Penicillin Resistance; Penicillins; Ticarcillin; Tobramycin | 1979 |
Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.
Topics: Amikacin; Animals; Extracellular Space; Female; Gentamicins; Injections, Intramuscular; Kinetics; Netilmicin; Rabbits; Sisomicin; Tobramycin | 1978 |
Aminoglycoside antibiotics moderately impair granulocyte function.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chemotaxis, Leukocyte; Gentamicins; Granulocytes; Kanamycin; Netilmicin; Phagocytosis; Tobramycin | 1978 |
Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Critical Care; Gentamicins; Humans; Kidney; Prospective Studies; Tobramycin | 1979 |
Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Gentamicins; Kanamycin; Meningitis; Rabbits; Sisomicin; Tobramycin | 1977 |
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Ear; Gentamicins; Humans; Kanamycin; Middle Aged; Pseudomonas; Sepsis; Serratia marcescens; Tobramycin | 1977 |
Inhibition of acetylating activity in an enzymatic assay for aminoglycoside antibiotics.
Topics: Acetylation; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteriological Techniques; Gentamicins; In Vitro Techniques; Kanamycin; Tobramycin | 1977 |
Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07..
Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Kanamycin; Male; Tobramycin | 1978 |
[Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)].
Topics: Amikacin; Cross Infection; Gentamicins; Humans; Microbial Sensitivity Tests; Serotyping; Serratia marcescens; Tobramycin | 1979 |
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens; Tobramycin | 1979 |
[Bactericidal activity of aminosides in a static system and in a dynamic model].
Topics: Amikacin; Aminoglycosides; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Methods; Microbial Sensitivity Tests; Pseudomonas; Serratia; Tobramycin | 1979 |
Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Humans; Kanamycin; Klebsiella; Proteus mirabilis; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1977 |
Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.
Topics: Amikacin; Bromthymol Blue; Carbenicillin; Citrates; Culture Media; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1977 |
In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics.
Topics: Amikacin; Gentamicins; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Sisomicin; Tobramycin | 1977 |
Antibiotic resistance transfer from nonpathogenic to pathogenic bacteria.
Topics: Alcaligenes; Amikacin; Animals; Anti-Bacterial Agents; Burns; Drug Resistance, Microbial; Gentamicins; Germ-Free Life; Intestines; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; R Factors; Sisomicin; Tobramycin | 1977 |
Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Burns; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1977 |
Gentamicin-resistant Pseudomonas aeruginosa: Mayo Clinic Experience, 1970-1976.
Topics: Amikacin; Carbenicillin; Drug Therapy, Combination; Gentamicins; Hospitals, General; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1977 |
Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Sisomicin; Tobramycin | 1977 |
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Topics: Agar; Amikacin; Anti-Bacterial Agents; Calcium; Depression, Chemical; Drug Synergism; Gentamicins; Kanamycin; Magnesium; Pseudomonas aeruginosa; Tobramycin | 1978 |
The effect of topical application of antibiotics on the cerebral cortex: an experimental update.
Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Carbenicillin; Cats; Cephalothin; Cerebral Cortex; Electroencephalography; Gentamicins; Kanamycin; Methicillin; Neomycin; Penicillins; Seizures; Time Factors; Tobramycin | 1979 |
Comments on current antibiotic therapy.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Minocycline; Nafcillin; Otorhinolaryngologic Diseases; Sulfamethoxazole; Surgical Procedures, Operative; Ticarcillin; Tobramycin; Trimethoprim | 1979 |
The comparative efficacy and safety of aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; South Africa; Tobramycin; Utilization Review | 1979 |
Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Chemical Phenomena; Chemistry; Drug Interactions; Gentamicins; Netilmicin; Osmolar Concentration; Temperature; Ticarcillin; Time Factors; Tobramycin | 1979 |
Aminoglycoside use monitored by clinical pharmaceutical services.
Topics: Amikacin; Anti-Bacterial Agents; California; Drug Utilization; Hospital Departments; Hospitals, University; Humans; Infections; Kanamycin; Pharmacy Service, Hospital; Tobramycin; Utilization Review | 1979 |
[Delayed elimination of aminoglycoside antibiotics: importance for clinical use].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Gentamicins; Half-Life; Humans; Tobramycin | 1979 |
[Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Species Specificity; Tobramycin | 1979 |
[Amikacin in the treatment of Gram negative bacilli septicemias].
Topics: Amikacin; Critical Care; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1979 |
[Comparative evaluation of the activity "in vitro" of 4 aminoglycosides (gentamycin, sisomicin, tobramycin, amikacin)].
Topics: Amikacin; Aminoglycosides; Bacteria; Gentamicins; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 1979 |
Some aspects of aminoglycoside antibiotic measurement.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Gentamicins; Humans; Tobramycin | 1979 |
[Comparative ototoxicity of aminoglycoside antibiotics in a guinea pig model (author's transl)].
Topics: Amikacin; Aminoglycosides; Animals; Child, Preschool; Cochlea; Ear; Gentamicins; Hearing Disorders; Humans; Organ of Corti; Sisomicin; Tobramycin | 1978 |
[Pharmacokinetical, histological, and histochemical investigation on the ototoxicity of gentamicin, tobramycin, and amikacin (author's transl)].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cochlea; Ear, Inner; Endolymph; Gentamicins; Guinea Pigs; Kanamycin; Tobramycin | 1977 |
[Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
Topics: Amikacin; Bacteria; Dibekacin; Drug Resistance, Microbial; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 1979 |
[Therapy of pyelonephritis].
Topics: Amikacin; Amoxicillin; Ampicillin; Carbenicillin; Cephalosporins; Chloramphenicol; Gentamicins; Humans; Nalidixic Acid; Penicillin Resistance; Pivampicillin; Pyelonephritis; Sulfonamides; Tetracyclines; Tobramycin; Trimethoprim | 1977 |
Microbiological considerations in the use of tobramycin and related aminoglycosidic aminocyclitol antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Inositol; Tobramycin | 1977 |
Comparative studies on activities of gentamicin, sisomicin, tobramycin and amikacin (BB-K8) against Pseudomonas sp.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Pseudomonas; Sisomicin; Tobramycin | 1977 |
Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Kanamycin; Sisomicin; Tobramycin | 1978 |
New developments in antimicrobial therapy.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Ticarcillin; Tobramycin | 1978 |
Gas-liquid chromatographic method for the assay of aminoglycoside antibiotics in serum.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chromatography, Gas; Chromatography, Liquid; Gentamicins; Humans; Methods; Sisomicin; Tobramycin | 1978 |
Antimicrobial therapy in the neonate.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Meningitis; Penicillins; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections | 1978 |
[Amikacin and tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Drug Resistance; Humans; Kanamycin; Tobramycin | 1978 |
Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.
Topics: Acoustic Stimulation; Amikacin; Animals; Anti-Bacterial Agents; Cochlea; Evoked Potentials; Gentamicins; Guinea Pigs; Hearing Disorders; Kanamycin; Reflex; Sisomicin; Time Factors; Tobramycin | 1978 |
[The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Klebsiella Infections; Pseudomonas; Sisomicin; Tobramycin | 1978 |
Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Tobramycin | 1978 |
[The clinical view of aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Sisomicin; Tobramycin | 1978 |
Measurement of three aminoglycosiee antibiotics with a single radioimmunoassay system.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Immune Sera; Kanamycin; Radioimmunoassay; Tobramycin | 1978 |
Prudent use of the aminoglycosides.
Topics: Amikacin; Aminoglycosides; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Drug Therapy, Combination; Ear; Gentamicins; Humans; Kanamycin; Kidney; Tobramycin | 1978 |
High-performance liquid-chromatographic assay of aminoglycoside antibiotics in serum.
Topics: Amikacin; Aminoglycosides; Biological Assay; Chromatography, High Pressure Liquid; Gentamicins; Humans; Tobramycin | 1978 |
[Ototoxicity of tobramycin and other aminoglycosides (comparative studies)].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Ear; Gentamicins; Guinea Pigs; Humans; Sisomicin; Tobramycin | 1978 |
Inactivation of netilmicin by carbenicillin.
Topics: Amikacin; Animals; Carbenicillin; Drug Interactions; Gentamicins; In Vitro Techniques; Netilmicin; Tobramycin | 1978 |
R plasmids coding for supra-levels of gentamicin, tobramycin and sisomicin resistance in Proteus morganii and P. mirabilis: high-level resistant strains from two hospitals.
Topics: Amikacin; Drug Resistance, Microbial; Gentamicins; Hospitals; Netilmicin; Proteus; R Factors; Sisomicin; Tobramycin | 1978 |
Renal accumulation of amikacin, tobramycin and gentamycin in the rat.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Gentamicins; Kanamycin; Kidney; Kidney Diseases; Rats; Solubility; Tobramycin | 1978 |
The nephrotoxicity and renal accumulation of amikacin, tobramycin and gentamycin in rats, rabbits and guinea pigs.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Gentamicins; Guinea Pigs; Kanamycin; Kidney; Organ Size; Rabbits; Rats; Tobramycin | 1978 |
Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Microbial Sensitivity Tests; Netilmicin; Sisomicin; Tobramycin | 1979 |
[Enzymatic quick determination of aminoglycoside antibiotics in serum].
Topics: Agar; Amikacin; Aminoglycosides; Biological Assay; Diffusion; Gentamicins; Humans; Proteus mirabilis; Sisomicin; Tobramycin; Urease | 1976 |
[Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Proteus; Pseudomonas; Serratia marcescens; Sisomicin; Staphylococcus aureus; Tobramycin | 1976 |
In-vitro comparison of four antipseudomonal antibiotics in a general hospital.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbenicillin; Child; Child, Preschool; Dose-Response Relationship, Drug; Gentamicins; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1976 |
Comparative evaluation of five aminoglycosides for treatment.
Topics: Amikacin; Aminoglycosides; Enterobacter; Escherichia coli; Gentamicins; Humans; Kanamycin; Kinetics; Klebsiella; Microbial Sensitivity Tests; Providencia; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin; Tobramycin | 1976 |
In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Enterobacteriaceae; Gentamicins; Pseudomonas; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1976 |
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Gentamicins; Penicillin Resistance; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1976 |
Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1976 |
In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
Topics: Amikacin; Carbenicillin; Culture Media; Enterobacteriaceae; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Providencia; Pseudomonas aeruginosa; Serratia; Sisomicin; Staphylococcus aureus; Tobramycin | 1976 |
In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin; Staphylococcus aureus; Tobramycin | 1976 |
Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
Topics: Amikacin; Aminoglycosides; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Moraxella; Neomycin; Paromomycin; Pseudomonas aeruginosa; Tobramycin | 1976 |
Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Paromomycin; Pseudomonas aeruginosa; Streptomycin; Tobramycin | 1976 |
In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Gentamicins; Species Specificity; Tobramycin | 1977 |
In vitro activity of netilmicin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Synergism; Gentamicins; Sisomicin; Tobramycin | 1977 |
Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Doxorubicin; Female; Gentamicins; Humans; Hypocalcemia; Hypoparathyroidism; Kidney Diseases; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone; Phosphates; Sisomicin; Syndrome; Tobramycin | 1977 |
Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Streptomycin; Tobramycin | 1977 |
[Determinants of resistance to various aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; R Factors; Sisomicin; Tobramycin | 1977 |
In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 1977 |
Gram-negative sepsis: part II. Management.
Topics: Acidosis; Adult; Amikacin; Child; Chloramphenicol; Clindamycin; Disseminated Intravascular Coagulation; Dopamine; Gentamicins; Heart Failure; Humans; Isoproterenol; Kanamycin; Kidney Diseases; Metaraminol; Phenoxybenzamine; Respiratory Insufficiency; Sepsis; Tobramycin | 1977 |
Comparative ototoxicity of BB-K8 (amikacin), gentamicin, sisomicin and tobramycin in the guinea pig.
Topics: Acoustic Stimulation; Amikacin; Animals; Anti-Bacterial Agents; Cochlea; Electrophysiology; Gentamicins; Guinea Pigs; Hearing Disorders; Kanamycin; Reflex; Sisomicin; Tobramycin | 1977 |
Toxicity of selected antibiotics in vitreous replacement fluid.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biocompatible Materials; Chloramphenicol; Clindamycin; Rabbits; Retina; Sodium Chloride; Tobramycin; Vitreous Body | 1977 |
[New aminoglycoside antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Kanamycin; Pseudomonas Infections; Tobramycin | 1977 |
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ear; Endolymph; Female; Gentamicins; Guinea Pigs; Kanamycin; Kinetics; Male; Perilymph; Tobramycin | 1976 |
Use of aminoglycosides in surgical infections.
Topics: Abscess; Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Male; Middle Aged; Peritonitis; Sepsis; Sisomicin; Surgical Wound Infection; Tobramycin; Wound Infection | 1976 |
Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides.
Topics: Amikacin; Aminoglycosides; Drug Resistance, Microbial; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Sisomicin; Staphylococcus aureus; Time Factors; Tobramycin | 1976 |
[New plasmid resistance of Staphylococcus aureus to aminosides (gentamicin, tobramycin, amikacin].
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Plasmids; Staphylococcus aureus; Tobramycin | 1976 |
Amikacin.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Kanamycin; Leukopenia; Tobramycin | 1976 |
Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Kanamycin; Sisomicin; Tobramycin | 1976 |
Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.
Topics: Amikacin; Creatinine; Drug Therapy; Ethambutol; Flucytosine; Gentamicins; Humans; Kanamycin; Models, Biological; Pentetic Acid; Pharmaceutical Preparations; Procainamide; Renal Dialysis; Tobramycin | 1976 |
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ataxia; Cats; Dogs; Enterobacteriaceae; Gentamicins; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas; Sisomicin; Staphylococcus aureus; Streptococcus; Tobramycin | 1976 |
[Ototoxicity of the aminoglycoside antibiotics (author's transl)].
Topics: Acid Phosphatase; Alkaline Phosphatase; Amikacin; Animals; Anti-Bacterial Agents; Child; Ear, Inner; Esterases; Ethacrynic Acid; Gentamicins; Guinea Pigs; Humans; Kidney Diseases; Noise; Otitis Media; Sisomicin; Sulfhydryl Compounds; Tobramycin | 1976 |
[Drug sensitivity of Yersinia enterocolitica and Yersinia pseudotuberculosis].
Topics: Amikacin; Animals; Antibiotics, Antitubercular; Cephalosporins; Chloramphenicol; Dogs; Gentamicins; Humans; Kanamycin; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Tetracyclines; Tobramycin; Yersinia | 1976 |
Effectiveness of carbenicillin - aminoglycoside and of cephalothin-aminoglycoside combinations against enterococci in vitro.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Cephalothin; Drug Antagonism; Drug Synergism; Gentamicins; Humans; Intestines; Kanamycin; Microbial Sensitivity Tests; Sisomicin; Streptococcus; Tobramycin | 1975 |
Improved acetylating radioenzymatic assay of amikacin, tobramycin, and sisomicin in serum.
Topics: Amikacin; Anti-Bacterial Agents; Coenzyme A; Kanamycin; Methods; Sisomicin; Tobramycin | 1975 |
Bacterial flora of appendicitis in children.
Topics: Aerobiosis; Amikacin; Anaerobiosis; Appendectomy; Appendicitis; Ascitic Fluid; Bacteria; Cephalothin; Child; Child, Preschool; Clindamycin; Female; Gangrene; Gentamicins; Humans; Male; Sisomicin; Tobramycin | 1976 |
In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Drug Synergism; Gentamicins; Kanamycin; Species Specificity; Tobramycin | 1976 |
In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1992 |
The pH of antibiotic vitreous infusion combinations: a potential cause of retinal toxicity.
Topics: Amikacin; Anti-Bacterial Agents; Buffers; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Methicillin; Ophthalmic Solutions; Retinal Diseases; Therapeutic Irrigation; Tobramycin; Vancomycin; Vitreous Body | 1992 |
Characterization of two plasmids from Campylobacter jejuni isolates that carry the aphA-7 kanamycin resistance determinant.
Topics: Amikacin; Campylobacter coli; Campylobacter jejuni; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Humans; Kanamycin Resistance; Microbial Sensitivity Tests; Plasmids; Streptococcus; Tobramycin | 1992 |
Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
Topics: Amikacin; Animals; Endocarditis, Bacterial; Enterobacter cloacae; Female; Gentamicins; Humans; Microbial Sensitivity Tests; Rabbits; Serratia marcescens; Tobramycin | 1992 |
Effects of aminoglycoside antibiotics on the auditory brainstem response and post rotatory nystagmus in rats.
Topics: Amikacin; Animals; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Male; Nystagmus, Physiologic; Rats; Rats, Inbred Strains; Tobramycin | 1992 |
Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues.
Topics: Abscess; Aerobiosis; Amikacin; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Drug Synergism; Enterobacteriaceae; Escherichia coli; Humans; Hydrogen-Ion Concentration; Mice; Oxygen; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1992 |
Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside.
Topics: Amikacin; Bacteremia; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Louisiana; Prospective Studies; Tobramycin | 1992 |
High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.
Topics: Amikacin; Anti-Bacterial Agents; Audiometry; Gentamicins; Hearing Loss; Hearing Loss, Bilateral; Hearing Loss, High-Frequency; Humans; Male; Middle Aged; Prospective Studies; Tobramycin | 1992 |
Variation in the isoenzymes of N-acetyl-beta-D-glucosaminidase and protein excretion in aminoglycoside nephrotoxicity in the rat.
Topics: Acetylglucosaminidase; Amikacin; Animals; Anti-Bacterial Agents; Isoenzymes; Kidney; Male; Proteinuria; Rats; Rats, Inbred Strains; Sisomicin; Tobramycin | 1991 |
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Drug Therapy, Combination; Gentamicins; Metronidazole; Solutions; Theophylline; Tobramycin | 1991 |
New epidemiological data on resistance to netilmicin and other aminoglycosides.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1991 |
Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.
Topics: Alginates; Amikacin; Anti-Bacterial Agents; Blood Bactericidal Activity; Glycoside Hydrolases; Humans; Neutrophils; Phagocytosis; Polysaccharide-Lyases; Pseudomonas aeruginosa; Tobramycin | 1991 |
Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serum Bactericidal Test; Time Factors; Tobramycin | 1991 |
An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
Topics: Acinetobacter; Amikacin; Cancer Care Facilities; Drug Resistance, Microbial; Drug Utilization; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Prospective Studies; Pseudomonas aeruginosa; R Factors; Tobramycin | 1991 |
Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1991 |
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization; Gentamicins; Gram-Negative Aerobic Bacteria; Hospitals, Veterans; Humans; Microbial Sensitivity Tests; Minnesota; Tobramycin | 1991 |
Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophage Typing; Culture Media; DNA, Recombinant; Drug Resistance, Microbial; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Nucleic Acid Hybridization; Nucleotidyltransferases; Plasmids; Pseudomonas aeruginosa; Pyocins; Tobramycin | 1990 |
Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage.
Topics: Acinetobacter Infections; Amikacin; Bacteriophage Typing; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; France; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Retrospective Studies; Serotyping; Tobramycin | 1990 |
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
Topics: Amikacin; Animals; Drug Administration Schedule; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Rabbits; Serratia marcescens; Tobramycin | 1991 |
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use.
Topics: Amikacin; Anti-Bacterial Agents; Endophthalmitis; Gentamicins; Humans; Infarction; Macula Lutea; Ophthalmology; Surveys and Questionnaires; Tobramycin; Vitrectomy; Vitreous Body | 1991 |
Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Amikacin; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1990 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
Topics: Amikacin; Anti-Bacterial Agents; Austria; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Pseudomonas aeruginosa; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Tobramycin | 1990 |
[In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
Topics: Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1990 |
The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing.
Topics: Amikacin; Anti-Bacterial Agents; Binding Sites; Binding, Competitive; Biological Transport, Active; Calcium; Cold Temperature; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1990 |
[The combined effects of aspoxicillin with aminoglycoside antibiotics on Pseudomonas aeruginosa].
Topics: Amikacin; Amoxicillin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Pseudomonas aeruginosa; Tobramycin | 1990 |
Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
Topics: Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Male; Pneumonia; Pseudomonas Infections; Tobramycin | 1990 |
Comparison of four methods for testing high-level aminoglycoside resistance in enterococci.
Topics: Amikacin; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Prospective Studies; Streptococcus; Streptomycin; Tobramycin | 1990 |
ERG and electron microscopic findings after intravitreal use of aminoglycosides.
Topics: Amikacin; Animals; Dose-Response Relationship, Drug; Electroretinography; Follow-Up Studies; Microscopy, Electron; Photoreceptor Cells; Pigment Epithelium of Eye; Rabbits; Retina; Tobramycin; Vitreous Body | 1990 |
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1989 |
Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.
Topics: Adaptation, Physiological; Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Drug Resistance, Microbial; Gentamicins; Lipids; Microscopy, Electron; Phosphatidylglycerols; Pseudomonas aeruginosa; Tobramycin | 1989 |
Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients.
Topics: Amikacin; Creatinine; Drug Administration Schedule; Gentamicins; Humans; Intensive Care Units; Kidney; Monitoring, Physiologic; Tobramycin; Vancomycin | 1989 |
In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Interactions; Gentamicins; Gram-Negative Bacteria; Lactams; Microbial Sensitivity Tests; Tobramycin | 1989 |
Aminoglycoside resistance patterns in Turkey.
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Nucleotidyltransferases; Tobramycin; Turkey | 1988 |
Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli.
Topics: Amikacin; Anti-Bacterial Agents; Chloramphenicol; Escherichia coli; Gentamicins; Kanamycin; Lipopolysaccharides; Spectinomycin; Tobramycin | 1988 |
Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kanamycin Kinase; Netilmicin; Nucleotidyltransferases; Phosphotransferases; Population Surveillance; Prospective Studies; Tobramycin | 1986 |
Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid.
Topics: Acetyltransferases; Amikacin; Cloning, Molecular; Conjugation, Genetic; DNA Restriction Enzymes; DNA, Bacterial; Genes, Bacterial; Gentamicins; Kanamycin; Kanamycin Kinase; Klebsiella pneumoniae; Phosphotransferases; R Factors; Tobramycin | 1986 |
[Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Topics: Amikacin; Anti-Bacterial Agents; Citrobacter; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Netilmicin; Phenotype; Plasmids; Proteus mirabilis; Proteus vulgaris; Serratia; Tobramycin | 1988 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Survey of aminoglycoside resistance patterns.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteriuria; Drug Resistance, Microbial; Escherichia coli; Exudates and Transudates; Gentamicins; Gram-Negative Bacteria; Humans; Klebsiella; Phenotype; Proteus; Pseudomonas aeruginosa; Respiratory System; Tobramycin | 1986 |
Cost-effective aminoglycoside therapy in surgical patients.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy; Gentamicins; Humans; Models, Theoretical; Premedication; Risk; Surgical Wound Infection; Tobramycin | 1986 |
Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Time Factors; Tobramycin | 1986 |
Surveillance of aminoglycoside resistance. European data.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Belgium; Drug Resistance, Microbial; Europe; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Prospective Studies; Pseudomonas aeruginosa; Tobramycin | 1986 |
Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
Topics: Amikacin; Carbenicillin; Cefoperazone; Gentamicins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Microbial; Enzyme Induction; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1987 |
Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefsulodin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin | 1987 |
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
Topics: Adult; Amikacin; Cations; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1987 |
Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis.
Topics: Amikacin; Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Drug Synergism; Enterococcus faecalis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillins; Predictive Value of Tests; Streptomycin; Time Factors; Tobramycin | 1988 |
High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.
Topics: Amikacin; Anti-Bacterial Agents; Culture Media; Drug Synergism; Enterococcus faecalis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillins; Streptomycin; Tobramycin | 1988 |
Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Belgium; Dibekacin; Drug Resistance, Microbial; Drug Utilization; Gentamicins; Hospitals, General; Humans; Netilmicin; Tobramycin | 1988 |
Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1988 |
[Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1988 |
[Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Ticarcillin; Tobramycin | 1988 |
Evaluation of a fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic.
Topics: Adult; Amikacin; Bilirubin; Biological Assay; Chromatography, High Pressure Liquid; Drug Interactions; Gentamicins; Hemolysis; Humans; Immunoassay; Male; Reproducibility of Results; Tobramycin | 1988 |
Treatment of chronic prostatitis: intraprostatic antibiotic injections under echography control.
Topics: Amikacin; Chronic Disease; Escherichia coli Infections; Humans; Injections; Male; Prostate; Prostatitis; Time Factors; Tobramycin; Ultrasonography | 1988 |
[Aminoside sensitivity of bacteria isolated in 1984 at the military hospital complex in the Paris region].
Topics: Acinetobacter; Amikacin; Aminoglycosides; Cross Infection; Enterobacteriaceae; Gentamicins; Hospitals, Military; Humans; Microbial Sensitivity Tests; Netilmicin; Paris; Pseudomonas; Sisomicin; Tobramycin | 1987 |
[Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin].
Topics: Amikacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Tobramycin | 1987 |
In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacteriuria; Drug Resistance, Microbial; Escherichia coli; Europe; Gentamicins; Humans; Netilmicin; Pseudomonas; Sepsis; Staphylococcus; Tobramycin | 1987 |
Aminoglycoside nephrotoxicity in obstructive jaundice.
Topics: Amikacin; Anti-Bacterial Agents; Cholangitis; Cholestasis; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Tobramycin | 1988 |
Individualized aminoglycoside dosage regimens in patients with cystic fibrosis.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Female; Gentamicins; Humans; Infant; Male; Spectrometry, Fluorescence; Tobramycin | 1988 |
Urinary enzyme release following aminoglycoside administration in single low dose.
Topics: Adult; Alkaline Phosphatase; Amikacin; Aminoglycosides; Dose-Response Relationship, Drug; Enzymes; Female; Gentamicins; Humans; L-Lactate Dehydrogenase; Leucyl Aminopeptidase; Male; Tobramycin | 1988 |
Compatibility and stability of clindamycin phosphate-aminoglycoside combinations within polypropylene syringes.
Topics: Amikacin; Anti-Bacterial Agents; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Stability; Gentamicins; Hydrogen-Ion Concentration; Polypropylenes; Syringes; Tobramycin | 1987 |
Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
Topics: Amikacin; Cefotaxime; Cefotiam; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1986 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Costs and Cost Analysis; Creatinine; Decision Making; Evaluation Studies as Topic; Gentamicins; Humans; Immunoenzyme Techniques; Kidney Diseases; Middle Aged; Prognosis; Time Factors; Tobramycin | 1986 |
[Diffusion of amikacin in the lungs].
Topics: Amikacin; Dibekacin; Diffusion; Humans; Kanamycin; Kinetics; Lung; Netilmicin; Tobramycin | 1986 |
Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis.
Topics: Acetyltransferases; Amikacin; Ampicillin; Cerebrospinal Fluid; Conjugation, Genetic; Cross Infection; DNA, Bacterial; Electrophoresis, Agar Gel; Escherichia coli; Humans; Infant, Newborn; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Meningitis; Nucleic Acid Hybridization; Penicillin Resistance; R Factors; Tobramycin | 1986 |
Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Blood Pressure; Cephalothin; Endotoxins; Escherichia coli; Female; Gentamicins; Half-Life; Kidney; Kidney Function Tests; Kinetics; Netilmicin; Pulse; Rats; Rats, Inbred Strains; Tobramycin | 1986 |
[Clinical and bacteriological study of O-demethylfortimicin A sulfate in urinary infection].
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tobramycin; Urinary Tract Infections | 1986 |
Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Enterobacteriaceae; Evaluation Studies as Topic; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pseudomonas; Software; Tobramycin | 1987 |
The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, and sisomicin.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Gentamicins; Humans; Netilmicin; Sisomicin; Streptomycin; Tobramycin | 1987 |
Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
Topics: Adult; Aged; Amikacin; Body Weight; Female; Gentamicins; Humans; Male; Middle Aged; Retrospective Studies; Tobramycin | 1987 |
More on variability in aminoglycoside volume of distribution.
Topics: Adult; Aged; Amikacin; Body Weight; Critical Care; Gentamicins; Humans; Middle Aged; Surgical Procedures, Operative; Tobramycin | 1987 |
[Antibiotic monitoring].
Topics: Amikacin; Anti-Bacterial Agents; Chloramphenicol; Drug Administration Schedule; Female; Gentamicins; Humans; Male; Monitoring, Physiologic; Reference Values; Streptomycin; Tobramycin | 1987 |
Aminoglycoside antibiotics. 6. Chemical reactions of aminoglycosides with disodium carbenicillin.
Topics: Acylation; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Chromatography, Thin Layer; Gentamicins; Humans; Kanamycin; Magnetic Resonance Spectroscopy; Tobramycin | 1986 |
In vitro inactivation of aminoglycosides by apalcillin.
Topics: Amikacin; Ampicillin; Drug Combinations; Drug Stability; Gentamicins; Kanamycin; Naphthyridines; Netilmicin; Time Factors; Tobramycin | 1986 |
Epidemiology of resistance to netilmicin and other aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Fermentation; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Tobramycin | 1986 |
Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Gentamicins; Humans; Kidney; Kidney Cortex; Lysosomes; Netilmicin; Phospholipids; Rats; Risk; Tobramycin | 1986 |
Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Tobramycin | 1986 |
In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
Topics: Amikacin; Aminoglycosides; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Staphylococcus; Sweden; Tobramycin | 1986 |
Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Blood; Drug Resistance, Microbial; Enterobacteriaceae; False Positive Reactions; Gentamicins; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas; Staphylococcus; Staphylococcus aureus; Tobramycin | 1986 |
Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital.
Topics: Acetyltransferases; Amikacin; DNA, Bacterial; Drug Utilization; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia; Time Factors; Tobramycin | 1986 |
Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides.
Topics: Adenosine Triphosphate; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Luminescent Measurements; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1986 |
Staphylococcal resistance to aminoglycosides before and after introduction of amikacin in two teaching hospitals.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Burn Units; Child; Drug Resistance, Microbial; Gentamicins; Humans; Infant, Newborn; Intensive Care Units; Intensive Care Units, Neonatal; Prospective Studies; Staphylococcus; Staphylococcus aureus; Tobramycin | 1986 |
Antibiotic stability in an implantable pump.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Stability; Gentamicins; Humans; Infusion Pumps; Microbial Sensitivity Tests; Netilmicin; Osteomyelitis; Tobramycin | 1986 |
Eosinophilia of the cerebrospinal fluid in a case of shunt infection: case report.
Topics: Amikacin; Anti-Bacterial Agents; Cerebral Ventricles; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Drug Hypersensitivity; Encephalitis; Eosinophilia; Female; Gentamicins; Granulocytes; Humans; Infant; Tobramycin | 1986 |
Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefsulodin; Humans; Male; Middle Aged; Pseudomonas Infections; Spinal Cord Injuries; Time Factors; Tobramycin; Urinary Tract Infections | 1986 |
The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats.
Topics: Amikacin; Aminoglycosides; Animals; Drug Administration Schedule; Female; Gentamicins; Infusions, Parenteral; Injections, Intraperitoneal; Kidney Cortex; Rats; Rats, Inbred Strains; Tobramycin | 1986 |
[The use of aminosides in the burn patient].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Burns; Humans; Netilmicin; Tobramycin | 1986 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
Topics: Amikacin; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Clindamycin; Drug Incompatibility; Drug Stability; Drug Storage; Freezing; Gentamicins; Immunoassay; Tobramycin | 1986 |
Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Netilmicin; Pseudomonas; Staphylococcus; Tobramycin | 1985 |
Susceptibility of some Staphylococcus species to aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Gentamicins; Methicillin; Microbial Sensitivity Tests; Netilmicin; Penicillin Resistance; Staphylococcus; Tobramycin | 1985 |
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
Topics: Amikacin; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Salmonella; Serratia; Staphylococcus; Streptococcus; Tobramycin | 1985 |
Effects of aminoglycoside antibiotics on polymorphonuclear leukocyte function in vivo.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Candida albicans; Cell Adhesion; Chemotaxis, Leukocyte; Humans; In Vitro Techniques; Netilmicin; Neutrophils; Phagocytosis; Tobramycin | 1985 |
[In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Cefotiam; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1985 |
Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.
Topics: Amikacin; Aminoglycosides; Dose-Response Relationship, Drug; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1985 |
Clinical and microbiologic consequences of amikacin use during a 42-month period.
Topics: Age Factors; Aged; Amikacin; Bacterial Infections; Catheterization; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Hospital Bed Capacity, 500 and over; Hospitalization; Hospitals, Veterans; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Tennessee; Tobramycin | 1986 |
Compatibility of furosemide with aminoglycoside admixtures.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Drug Combinations; Drug Incompatibility; Furosemide; Gentamicins; Hydrogen-Ion Concentration; Kanamycin; Netilmicin; Tobramycin | 1985 |
Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Female; Gentamicins; Humans; Infusions, Parenteral; Kanamycin; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Tears; Tobramycin | 1985 |
Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
Topics: Amikacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1985 |
Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Blood Proteins; Dibekacin; Electrolytes; Gentamicins; Glomerular Filtration Rate; Humans; Kidney Tubules; L-Lactate Dehydrogenase; Male; Netilmicin; Protein Binding; Tobramycin | 1985 |
Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization; Gentamicins; Gram-Negative Bacteria; Hospitals, Veterans; Humans; Kanamycin; Minnesota; Time Factors; Tobramycin; United States | 1985 |
Comparative toxicity of intravitreal aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Basement Membrane; Electroretinography; Gentamicins; Injections; Kanamycin; Microscopy, Electron; Netilmicin; Pigment Epithelium of Eye; Rabbits; Retina; Rod Cell Outer Segment; Tobramycin; Vitreous Body | 1985 |
Aminoglycoside antibiotics and lysosomal enzymes of human tears.
Topics: Acetylglucosaminidase; Acid Phosphatase; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Depression, Chemical; Dibekacin; Erythromycin; Gentamicins; Hexosaminidases; Humans; Kanamycin; Muramidase; Sulbenicillin; Tears; Tobramycin | 1985 |
Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1974 |
Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK1): a model system for aminoglycoside nephrotoxicity.
Topics: Adenosine Triphosphate; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cell Count; Cell Line; Cyclic AMP; Epithelial Cells; Gentamicins; Kidney; Microscopy, Electron; Neomycin; Swine; Tobramycin | 1984 |
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Netilmicin; Species Specificity; Tobramycin | 1984 |
Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
Topics: Alkaline Phosphatase; Amikacin; Aminoglycosides; Aminopeptidases; Animals; Anti-Bacterial Agents; CD13 Antigens; Computers; Enzyme Induction; Gentamicins; Glucuronidase; Kanamycin; Kidney Tubules, Proximal; Male; Microscopy, Electron; Rats; Rats, Inbred Strains; Staining and Labeling; Tobramycin | 1982 |
Amikacin, gentamicin and tobramycin resistant Pseudomonas aeruginosa in a leukaemic ward. Epidemiology and genetic studies.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Gentamicins; Humans; Leukemia; Male; Middle Aged; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Urinary Tract Infections | 1982 |
[Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
Topics: Adolescent; Adult; Aged; Amikacin; Azlocillin; Drug Therapy, Combination; Female; Humans; Male; Meningitis; Middle Aged; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1984 |
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
Topics: Amikacin; Aminoglycosides; Cefotaxime; Cefotiam; Drug Interactions; Enterobacteriaceae; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Netilmicin; Proteus; Staphylococcus; Tobramycin | 1981 |
Aminoglycoside-induced cochlear pathology in man.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Child; Cochlea; Female; Gentamicins; Hair Cells, Auditory; Hearing Loss, Bilateral; Humans; Labyrinth Diseases; Male; Middle Aged; Neomycin; Organ of Corti; Spiral Lamina; Temporal Bone; Tobramycin | 1981 |
In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefotaxime; Ceftriaxone; Drug Synergism; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1983 |
Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Topics: Acetyltransferases; Amikacin; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Netilmicin; Nurseries, Hospital; Serratia marcescens; Tobramycin | 1983 |
In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Leukopenia; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1983 |
Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Enterococcus faecalis; Gentamicins; Microbial Sensitivity Tests; Streptococcus; Time Factors; Tobramycin | 1983 |
Aminoglycoside resistance among blood culture isolates.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Blood; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Finland; Gentamicins; Humans; In Vitro Techniques; Klebsiella; Netilmicin; Proteus mirabilis; Pseudomonas; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Tobramycin | 1984 |
Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.
Topics: Amikacin; Aminoglycosides; Evaluation Studies as Topic; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Reference Standards; Tobramycin | 1983 |
Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gentamicins; In Vitro Techniques; Kidney; Lysosomes; Netilmicin; Rats; Time Factors; Tissue Distribution; Tobramycin | 1983 |
Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
Topics: Amikacin; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1983 |
Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.
Topics: Amikacin; Evaluation Studies as Topic; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1984 |
A laboratory assessment of the activities of four aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacter; Gentamicins; Klebsiella; Netilmicin; Pseudomonas aeruginosa; Serratia marcescens; Tobramycin | 1984 |
Effect of aminoglycoside-use restrictions on drug cost.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Costs and Cost Analysis; Creatinine; Drug Utilization; Formularies, Hospital as Topic; Gentamicins; Hospital Bed Capacity, 300 to 499; Pseudomonas aeruginosa; Rhode Island; Tobramycin | 1984 |
Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
Topics: Amikacin; Antibiotics, Antitubercular; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Lincomycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Netilmicin; Nontuberculous Mycobacteria; Tobramycin | 1984 |
[Chemotherapy of leptospirosis--effects of tobramycin, dibekacin and amikacin on the Leptospira].
Topics: Amikacin; Dibekacin; Drug Resistance, Microbial; Humans; Kanamycin; Leptospira; Leptospirosis; Tobramycin | 1984 |
[Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1984 |
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Tobramycin | 1984 |
In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1983 |
In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Drug Interactions; Gentamicins; Humans; In Vitro Techniques; Penicillins; Piperacillin; Radioimmunoassay; Tobramycin | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin | 1981 |
Colorimetric determination of gentamicin, kanamycin, tobramycin, and amikacin aminoglycosides with 2,4-dinitrofluorobenzene.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Colorimetry; Dinitrofluorobenzene; Gentamicins; Kanamycin; Nitrobenzenes; Tobramycin | 1984 |
Comparative ototoxicity of four aminoglycosidic antibiotics during the critical period of cochlear development in the rat. A functional and structural study.
Topics: Action Potentials; Amikacin; Aminoglycosides; Animals; Animals, Newborn; Anti-Bacterial Agents; Cochlea; Cochlear Microphonic Potentials; Dibekacin; Ear; Gentamicins; Hair Cells, Auditory; Microscopy, Electron, Scanning; Rats; Tobramycin | 1983 |
Evaluation of cochlear toxicity of aminoglycoside antibiotics in guinea pigs by scanning electron microscopy.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Dibekacin; Gentamicins; Guinea Pigs; Kanamycin; Ribostamycin; Tobramycin | 1983 |
Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Gentamicins; Hospitals, Military; Humans; Tobramycin | 1983 |
Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Chemistry, Pharmaceutical; Drug Combinations; Drug Stability; Gentamicins; Temperature; Tobramycin | 1983 |
Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Child; Gentamicins; Humans; Immunoassay; Tobramycin | 1983 |
Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Interactions; Gentamicins; Humans; Penicillins; Tobramycin | 1983 |
Quantitation of amikacin, kanamycin, neomycin, and tobramycin in pharmaceutical dosage forms using the Hantzsch reaction.
Topics: Amikacin; Anti-Bacterial Agents; Capsules; Chemistry, Pharmaceutical; Excipients; Injections; Kanamycin; Neomycin; Solutions; Spectrophotometry; Tablets; Tobramycin | 1983 |
[Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
Topics: Amikacin; Bacteria; Bacterial Infections; Drug Interactions; Drug Resistance, Microbial; Ear; Gentamicins; Humans; Kanamycin; Kidney; Tobramycin | 1983 |
[Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Sisomicin; Tobramycin; Urinary Tract Infections | 1983 |
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
Topics: Adult; Aged; Amikacin; Body Temperature; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kidney Diseases; Leukocyte Count; Middle Aged; Proteus Infections; Sepsis; Statistics as Topic; Tobramycin | 1984 |
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
Topics: Amikacin; Aminoglycosides; Chicago; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Netilmicin; Pseudomonadaceae; Pseudomonas aeruginosa; Tobramycin; Urine | 1980 |
Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gentamicins; Guinea Pigs; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1980 |
Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Culture Media; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; F Factor; Gentamicins; Kanamycin; Lysogeny; Pseudomonas aeruginosa; Tobramycin; Transduction, Genetic | 1980 |
Distribution of Pseudomonas aeruginosa serotypes in bacteriologic specimens and their aminoglycoside resistance.
Topics: Amikacin; Aminoglycosides; Drug Resistance, Microbial; Female; Gentamicins; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping; Sisomicin; Tobramycin | 1980 |
Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Colistin; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Bacteria; Escherichia coli; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1980 |
A long-term study of gentamicin-resistant Pseudomonas aeruginosa in a general hospital.
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals, General; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1981 |
An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides.
Topics: Amikacin; Aminoglycosides; False Negative Reactions; False Positive Reactions; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1981 |
Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
Topics: Amikacin; Animals; Carbenicillin; Gentamicins; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sisomicin; Ticarcillin; Tobramycin | 1981 |
Cefoxitin: synergism with aminoglycosides in vitro.
Topics: Amikacin; Cefoxitin; Dibekacin; Drug Synergism; Escherichia coli; Gentamicins; Kanamycin; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophages; Genes, Bacterial; Gentamicins; Kanamycin; Pseudomonas aeruginosa; R Factors; Tobramycin; Transduction, Genetic | 1981 |
The screening of four aminoglycosides in the selective decontamination of the digestive tract in mice.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Female; Gentamicins; Intestines; Klebsiella pneumoniae; Mice; Paromomycin; Tobramycin | 1982 |
[Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
Topics: Amikacin; Anti-Bacterial Agents; Calcium; Culture Media; Dose-Response Relationship, Drug; Gentamicins; Humans; Kanamycin; Magnesium; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1982 |
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1982 |
[Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1982 |
The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Sisomicin; Streptomycin; Tobramycin | 1983 |
Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin.
Topics: Adolescent; Amikacin; Animals; Anti-Bacterial Agents; Drug Synergism; Female; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intubation, Intratracheal; Kanamycin; Magnesium Sulfate; Male; Mice; Mice, Inbred Strains; Neuromuscular Diseases; Rabbits; Respiratory Insufficiency; Tobramycin | 1983 |
Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
Topics: Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Creatinine; Female; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kinetics; Male; Middle Aged; Tobramycin | 1983 |
A comparison of the myocardial depressant effects of several aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Depression, Chemical; Female; Gentamicins; Guinea Pigs; In Vitro Techniques; Myocardial Contraction; Paromomycin; Tobramycin | 1981 |
[In vitro sensitivity of Salmonella strains to commonly used antibiotics and to some drugs which are not yet used in Turkey].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Salmonella; Sulfamethoxazole; Tobramycin; Trimethoprim; Turkey | 1981 |
Netilmicin treatment of complicated urinary tract infections.
Topics: Aged; Amikacin; Gentamicins; Humans; Kinetics; Male; Middle Aged; Netilmicin; Tobramycin; Urinary Tract Infections | 1980 |
Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cephalothin; Cephapirin; Child; Child, Preschool; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Random Allocation; Sepsis; Tobramycin | 1981 |
Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
Topics: Amikacin; Aminoglycosides; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Male; Meningitis; Plasmids; Serratia marcescens; Tobramycin | 1980 |
Gentamicin-resistant Serratia marcescens endophthalmitis.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Drug Resistance, Microbial; Endophthalmitis; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Middle Aged; Serratia marcescens; Tobramycin | 1980 |
Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital.
Topics: Amikacin; Chromosome Deletion; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Extrachromosomal Inheritance; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; R Factors; Tobramycin; Trimethoprim | 1980 |
Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Kanamycin; Proteus mirabilis; Providencia; Tobramycin | 1981 |
Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.
Topics: Amikacin; Aminoglycosides; Cross Reactions; Fluorescent Antibody Technique; Gentamicins; Humans; Immune Sera; Plasma; Tobramycin | 1981 |
In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; R Factors; Tobramycin | 1982 |
Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosides.
Topics: Amikacin; Aminoglycosides; False Negative Reactions; Gentamicins; Heparin; Humans; Immunoenzyme Techniques; Radioimmunoassay; Reagent Kits, Diagnostic; Reference Values; Tobramycin | 1982 |
[Proposed use of a technic based on bioluminescence for determination of the minimal inhibiting concentration (MIC)].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Escherichia coli; Gentamicins; Luminescent Measurements; Tobramycin | 1981 |
Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Rats; Rats, Inbred Strains; Sepsis; Sisomicin; Tobramycin | 1982 |
[Pathogenic flora in hematology patients. Gram-negative germs and their in vitro sensitivity to antibiotics].
Topics: Amikacin; Drug Resistance, Microbial; Gentamicins; Hematologic Diseases; Humans; In Vitro Techniques; Pseudomonas; Pseudomonas Infections; Sisomicin; Tobramycin | 1982 |
Change in serum pH in the bioassay of aminoglycoside antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Biological Assay; Gentamicins; Humans; Hydrogen-Ion Concentration; Kanamycin; Tobramycin | 1982 |
[Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Tobramycin | 1982 |
[Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Humans; Kanamycin; Kidney Failure, Chronic; Radioimmunoassay; Tobramycin | 1982 |
Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Gentamicins; Microbial Sensitivity Tests; Peritoneal Dialysis; Solutions; Tobramycin | 1982 |
[Resistance to aminoglycosides among gram - negative bacteria].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Tobramycin | 1982 |
[Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Dibekacin; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests; Tobramycin | 1982 |
[Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Female; Gentamicins; Kidney; Rats; Rats, Inbred Strains; Tobramycin | 1982 |
Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Body Weight; Cochlea; Ear Diseases; Electrophysiology; Female; Gentamicins; Guinea Pigs; Hearing Disorders; Male; Netilmicin; Tobramycin | 1982 |
Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Topics: Amikacin; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Microbial; Gentamicins; Gram-Negative Aerobic Bacteria; Hospitals, Teaching; Humans; Kanamycin; Tobramycin | 1981 |
Evaluation of a method for enzymic radiochemical assay of tobramycin and amikacin in serum.
Topics: Amikacin; Anti-Bacterial Agents; Bilirubin; Carbon Radioisotopes; Cross Reactions; Evaluation Studies as Topic; Hemoglobins; Humans; Kanamycin; Radioimmunoassay; Reagent Kits, Diagnostic; Tobramycin; Triglycerides | 1981 |
Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion.
Topics: Amikacin; Anti-Bacterial Agents; Bronchi; Humans; Infusions, Parenteral; Kanamycin; Pseudomonas; Tobramycin | 1981 |
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefamandole; Cefoxitin; Cephalosporins; Gentamicins; Humans; Methods; Tobramycin | 1981 |
A closer look at aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Interactions; Drug Resistance, Microbial; Gentamicins; Humans; Kidney; Tobramycin | 1981 |
[Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
Topics: Amikacin; Aminoglycosides; Bacteria; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus; Tobramycin | 1981 |
Comparative evaluation of the neuromuscular blocking activity of three new aminoglycoside antibiotics in rats.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Calcium Chloride; Drug Interactions; Male; Neostigmine; Neuromuscular Blocking Agents; Rats; Rats, Inbred Strains; Ribostamycin; Tobramycin | 1981 |
[An evaluation of ototoxicity of aminoglycoside antibiotics in rabbits (author's transl)].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Gentamicins; Hair Cells, Auditory; Kanamycin; Rabbits; Tobramycin | 1981 |
The effect of aminoglycosides on glomerular endothelium: a comparative study.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Endothelium; Kidney Glomerulus; Male; Netilmicin; Rats; Rats, Inbred Strains; Tobramycin | 1981 |
Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dogs; Female; Gentamicins; Injections, Subcutaneous; Kanamycin; Male; Tobramycin | 1981 |
Inhibition of candidacidal activity of human neutrophil leukocytes by aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Candida; Gentamicins; Humans; Neutrophils; Ribostamycin; Sisomicin; Tobramycin | 1980 |
Netilmicin: its in vitro activity and synergism with penicillin compounds.
Topics: Amikacin; Bacteria; Drug Synergism; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Netilmicin; Penicillins; Pseudomonas Infections; Sisomicin; Tobramycin | 1980 |
Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Netilmicin; Sisomicin; Tobramycin | 1980 |
In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Fermentation; Gentamicins; Glucose; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Pseudomonas; Staphylococcus; Streptococcus; Tobramycin | 1980 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin | 1980 |
Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Netilmicin; Sisomicin; Tobramycin | 1980 |
Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gentamicins; Kanamycin; Kidney; Male; Rats; Tobramycin | 1980 |
Gentamicin vs. tobramycin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Costs and Cost Analysis; Dogs; Gentamicins; Humans; Kidney Diseases; Tobramycin | 1980 |
[The distribution of aminoglycoside antibiotics into the lymph and pancreatic fluid in dogs (author's transl)].
Topics: Aged; Amikacin; Animals; Anti-Bacterial Agents; Dibekacin; Dogs; Female; Gentamicins; Humans; Kanamycin; Lymph; Male; Pancreatic Juice; Tobramycin | 1980 |
Effects of combinations of clindamycin with gentamicin, tobramycin, and amikacin against Staphylococcus aureus.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clindamycin; Drug Interactions; Gentamicins; Microbial Sensitivity Tests; Staphylococcus aureus; Tobramycin | 1980 |
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Sisomicin; Tobramycin | 1980 |
Stability of amikacin, gentamicin, or tobramycin in 10% dextrose injection.
Topics: Amikacin; Drug Stability; Drug Storage; Gentamicins; Glucose; Infusions, Intravenous; Solutions; Tobramycin | 1994 |
Postantibiotic effect of aminoglycosides on staphylococci.
Topics: Amikacin; Anti-Bacterial Agents; Dicloxacillin; Gentamicins; Luminescent Measurements; Microbial Sensitivity Tests; Netilmicin; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Tobramycin | 1993 |
[Detection of the phenotypes of resistance of enterobacteriaceae to aminoglycosides with ATB Plus Expert System].
Topics: Amikacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; In Vitro Techniques; Kanamycin; Kanamycin Resistance; Microbiological Techniques; Netilmicin; Phenotype; Tobramycin | 1993 |
Measurement of antimicrobial agents in cerebrospinal fluid using the Abbott TDx analyzer.
Topics: Amikacin; Anti-Bacterial Agents; Fluorescence Polarization Immunoassay; Gentamicins; Humans; Tobramycin; Vancomycin | 1993 |
Synthesis of 5-deoxy-5-epifluoro derivatives of arbekacin, amikacin, and 1-N-[(S)-4-amino-2-hydroxybutanoyl]tobramycin (study on structure--toxicity relationships).
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Carbohydrate Conformation; Carbohydrate Sequence; Dibekacin; Fluorine Compounds; Mice; Molecular Sequence Data; Tobramycin | 1995 |
Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Drug Carriers; Drug Compounding; Gentamicins; Humans; Kinetics; Liposomes; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1995 |
pH modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside acetyltransferase.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Drug Resistance, Microbial; Gentamicins; Hydrogen-Ion Concentration; Kinetics; Netilmicin; Staphylococcus epidermidis; Structure-Activity Relationship; Substrate Specificity; Tobramycin | 1996 |
Topical treatment of Pseudomonas sp-infected corneal ulcers in horses: 70 cases (1977-1994).
Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Corneal Ulcer; Female; Gentamicins; Horse Diseases; Horses; Male; Pseudomonas Infections; Retrospective Studies; Tobramycin | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapy.
Topics: Amikacin; Anti-Bacterial Agents; Drug Incompatibility; Drug Stability; Gentamicins; Humans; Microbial Sensitivity Tests; Solutions; Syringes; Tobramycin | 1996 |
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1996 |
Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
Topics: Amikacin; Anti-Bacterial Agents; Cross Reactions; Fluorescence Polarization Immunoassay; Gentamicins; Humans; Reproducibility of Results; Tobramycin; Vancomycin | 1997 |
[Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Tobramycin | 1997 |
Use of antibiotic-impregnated polymethyl methacrylate in horses with open or infected fractures or joints: 19 cases (1987-1995).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefazolin; Combined Modality Therapy; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fracture Fixation, Internal; Fractures, Open; Gentamicins; Horse Diseases; Horses; Joint Diseases; Joints; Osteomyelitis; Polymethyl Methacrylate; Retrospective Studies; Synovitis; Tobramycin | 1997 |
Aerosolized antimicrobials: another look.
Topics: Aerosols; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cytokines; Humans; Lung; Lung Diseases; Nebulizers and Vaporizers; Respiration, Artificial; Tobramycin; Ventilators, Mechanical | 1998 |
Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cell Wall; Chemical Phenomena; Chemistry, Physical; Electrophoresis, Polyacrylamide Gel; Gentamicins; Shigella dysenteriae; Tobramycin | 1997 |
In vivo simulation of human pharmacokinetics in the rabbit.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Humans; Mathematics; Mice; Models, Biological; Pharmacokinetics; Rabbits; Rats; Tobramycin | 1998 |
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E | 1998 |
Parameterization of inoculum effect via mathematical modeling: aminoglycosides against Staphylococcus aureus and Escherichia coli.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Models, Biological; Regression Analysis; Staphylococcus aureus; Streptomycin; Tobramycin | 1998 |
Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
Topics: Amikacin; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Ethidium; Fluorescent Dyes; Gentamicins; Humans; Kanamycin Resistance; Microbial Sensitivity Tests; Neomycin; R Factors; Tobramycin | 1998 |
Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Biological Assay; Blood Donors; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serum Bactericidal Test; Tobramycin | 1998 |
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin | 1995 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Europe; Gentamicins; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Sentinel Surveillance; Tobramycin | 1999 |
Operator error: a critical determinant of false amikacin and tobramycin concentrations using fluorescence polarization immunoassay kits and TDX analyzer.
Topics: Amikacin; Dose-Response Relationship, Drug; Fluorescence Polarization Immunoassay; Humans; Medical Errors; Reagent Kits, Diagnostic; Tobramycin | 1999 |
[The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Piperacillin; Tobramycin | 2000 |
[In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Netilmicin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 2000 |
Adaptive resistance to benzalkonium chloride, amikacin and tobramycin: the effect on susceptibility to other antimicrobials.
Topics: Adaptation, Physiological; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Benzalkonium Compounds; Drug Resistance, Bacterial; Lipids; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2002 |
Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Cells, Cultured; Codon, Nonsense; DNA, Complementary; Genes, Reporter; Gentamicins; Humans; Iduronidase; Mammals; Molecular Biology; Mucopolysaccharidosis I; Mutation; Plasmids; Protein Biosynthesis; Rats; Tobramycin; Tumor Suppressor Protein p53 | 2002 |
Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.
Topics: Amikacin; Anti-Bacterial Agents; Drug Carriers; Drug Delivery Systems; Gentamicins; Humans; In Vitro Techniques; Models, Immunological; Osteomyelitis; Polymethyl Methacrylate; Reproducibility of Results; Time Factors; Tobramycin; Vancomycin; Vasodilator Agents | 2002 |
Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic Systems.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Monitoring; Female; Fluorescence Polarization Immunoassay; Humans; Male; Middle Aged; Pharmacokinetics; Tobramycin; Vancomycin | 2002 |
[Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Tobramycin | 2002 |
[Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
A new micellar electrokinetic capillary chromatography method for separation of the components of the aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Chromatography, Micellar Electrokinetic Capillary; Deoxycholic Acid; Gentamicins; Hydrogen-Ion Concentration; Kanamycin; Netilmicin; Sisomicin; Temperature; Tobramycin | 2003 |
Some properties of Plesiomonas shigelloides treated with aminoglycosides.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Netilmicin; Oxidative Stress; Plesiomonas; Polysorbates; Surface-Active Agents; Tobramycin | 2003 |
[Conserved region analysis of aac(3)-II gene from E. coli aminoglycoside resistance strain].
Topics: Acetyltransferases; Amikacin; Amino Acid Sequence; Aminoglycosides; Base Sequence; Conserved Sequence; DNA; Drug Resistance, Multiple, Bacterial; Escherichia coli; Genes, Bacterial; Gentamicins; Point Mutation; Tobramycin | 2004 |
Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Tobramycin | 2005 |
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin | 2004 |
Evaluation on the use of beta-lactamase and aminoglycoside modifying enzyme gene sequences as markers for the early detection of antibiotic resistance profile of Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Biomarkers; Biotin; Blotting, Southern; Cross Infection; DNA; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Electrophoresis, Agar Gel; Gentamicins; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Penicillins; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Sequence Analysis, DNA; Streptomycin; Tobramycin | 2004 |
Rapid and selective micellar electrokinetic chromatography for simultaneous determination of amikacin, kanamycin A, and tobramycin with UV detection and application in drug formulations.
Topics: Alkanesulfonic Acids; Amikacin; Chromatography, Micellar Electrokinetic Capillary; Hydrogen-Ion Concentration; Kanamycin; Pharmaceutical Preparations; Spectrophotometry, Ultraviolet; Tobramycin; Tromethamine | 2005 |
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
Topics: Alanine; Amikacin; Amino Acid Substitution; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Blotting, Western; Cells, Cultured; Codon, Terminator; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Epithelial Cells; Exons; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Gene Deletion; HeLa Cells; Homozygote; Humans; Immunohistochemistry; Indoles; Kinetics; Muscular Atrophy, Spinal; Nerve Tissue Proteins; RNA-Binding Proteins; SMN Complex Proteins; Survival of Motor Neuron 1 Protein; Survival of Motor Neuron 2 Protein; Tissue Distribution; Tobramycin; Transcription, Genetic | 2005 |
In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Sisomicin; Staphylococcus aureus; Tobramycin | 1974 |
Aminoglycoside monitoring: perspective on current trends in the Western Cape.
Topics: Amikacin; Aminoglycosides; Humans; Netilmicin; South Africa; Tobramycin | 2005 |
Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
Topics: Amikacin; Bacillus; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1989 |
[Evaluation of aminoglycoside resistance phenotypes and genotyping of acetyltransferase in Escherichia coli].
Topics: Acyltransferases; Amikacin; Aminoglycosides; Drug Resistance, Bacterial; Escherichia coli; Genotype; Gentamicins; Phenotype; Tobramycin | 2006 |
[Vestibular tests in infants after treatment with aminoglycosides].
Topics: Amikacin; Anti-Bacterial Agents; Drug Combinations; Female; Gentamicins; Humans; Infant; Male; Respiratory Tract Infections; Tobramycin; Vestibular Function Tests | 2005 |
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cystatin C; Cystatins; Drug Monitoring; Female; Gentamicins; Glomerular Filtration Rate; Hepatic Insufficiency; Humans; Male; Metabolic Clearance Rate; Middle Aged; Tobramycin; Vancomycin | 2006 |
Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Chronic Disease; Cystic Fibrosis; Female; Humans; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin | 2006 |
Effect of intratympanic application of aminoglycosides on click-evoked myogenic potentials in Guinea pigs.
Topics: Acoustic Stimulation; Amikacin; Aminoglycosides; Animals; Caloric Tests; Electromyography; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Female; Gentamicins; Guinea Pigs; Microscopy, Electron; Reaction Time; Saccule and Utricle; Semicircular Canals; Tobramycin; Tympanic Membrane; Vestibule, Labyrinth | 2007 |
Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Topics: Amikacin; Aminoglycosides; Antitubercular Agents; Colony Count, Microbial; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Mycobacterium tuberculosis; Nocardia asteroides; Nontuberculous Mycobacteria; Prevalence; Streptomycin; Tobramycin | 2006 |
Interaction of neomycin, tobramycin and amikacin with melanin in vitro in relation to aminoglycosides-induced ototoxicity.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dihydroxyphenylalanine; Drug Interactions; Hearing Disorders; Indicators and Reagents; Kinetics; Melanins; Neomycin; Protein Binding; Tobramycin | 2007 |
[The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests; Neomycin; Netilmicin; Phenotype; Pseudomonas aeruginosa; Tobramycin | 2006 |
[Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Catheterization; Colistin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin | 2008 |
Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Body Surface Area; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Forecasting; Gentamicins; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Tobramycin | 2008 |
Determination of kanamycin A, amikacin and tobramycin residues in milk by capillary zone electrophoresis with post-column derivatization and laser-induced fluorescence detection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Residues; Electrophoresis, Capillary; Fluorescence; Hydrogen-Ion Concentration; Kanamycin; Linear Models; Milk; Sensitivity and Specificity; Tobramycin | 2009 |
Characterization of conjugative plasmids carrying antibiotic resistance genes encoding 16S rRNA methylase, extended-spectrum beta-lactamase, and/or plasmid-mediated AmpC beta-lactamase.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Gene Transfer, Horizontal; Gentamicins; Humans; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymorphism, Restriction Fragment Length; Tobramycin | 2009 |
In vitro interference of Hyptis martiusii Benth. & chlorpromazine against an aminoglycoside-resistant Escherichia coli.
Topics: Amikacin; Anti-Bacterial Agents; Chlorpromazine; Drug Synergism; Escherichia coli; Hyptis; In Vitro Techniques; Indicator Dilution Techniques; Kanamycin; Microbial Sensitivity Tests; Plant Extracts; Tobramycin | 2009 |
Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Adult; Aerosols; Amikacin; Anti-Bacterial Agents; APACHE; Colistin; Critical Illness; Drug Resistance, Multiple; Female; Glasgow Coma Scale; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Tobramycin; Treatment Outcome | 2009 |
Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Cluster Analysis; Computational Biology; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Gentamicins; Microbial Sensitivity Tests; Microbiological Techniques; Oligonucleotide Array Sequence Analysis; Open Reading Frames; Phenotype; Pseudomonas aeruginosa; Tobramycin | 2009 |
Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
Topics: Acute Kidney Injury; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Female; Gentamicins; Glomerular Filtration Rate; Hospitalization; Humans; Incidence; Infant; Intensive Care Units; Length of Stay; Male; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Rate; Tobramycin; Treatment Outcome | 2011 |
Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carboplatin; Cisplatin; Cross-Sectional Studies; Female; Gentamicins; Hearing Tests; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Risk; Time Factors; Tinnitus; Tobramycin; Vancomycin; Veterans | 2010 |
Polymethyl-methacrylate-sorbitol-based capsules as local drug delivery vehicles: an in vitro antibiotic elution study.
Topics: Amikacin; Anti-Bacterial Agents; Capsules; Diffusion; Drug Carriers; Gentamicins; Kinetics; Microbial Sensitivity Tests; Polymethyl Methacrylate; Sorbitol; Tobramycin | 2011 |
Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
Topics: Adult; Aeromonas hydrophila; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Fresh Water; Humans; Male; Microbial Sensitivity Tests; Soft Tissue Infections; Tobramycin; Wounds and Injuries | 2011 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
Topics: Amikacin; Burkholderia cepacia; Cystic Fibrosis; Drug Synergism; Fusidic Acid; Humans; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2011 |
A simple method of staging AKI in children.
Topics: Acute Kidney Injury; Amikacin; Anti-Bacterial Agents; Female; Gentamicins; Humans; Male; Tobramycin | 2011 |
Post-operative ocular infection due to Streptococcus dysgalactiae subspecies equisimilis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cataract Extraction; Cefazolin; DNA, Bacterial; DNA, Ribosomal; Endophthalmitis; Female; Humans; Male; Middle Aged; Molecular Sequence Data; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus; Surgical Wound Infection; Tobramycin; Treatment Outcome | 2011 |
[In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2011 |
Achromobacter xylosoxidans keratitis after contact lens usage.
Topics: Achromobacter denitrificans; Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Contact Lenses, Extended-Wear; Female; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; Keratitis; Tobramycin | 2012 |
The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Netilmicin; Rabbits; Time Factors; Tobramycin | 2012 |
Roseomonas keratitis after remote penetrating keratoplasty.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Corneal Perforation; Corneal Ulcer; Eye Infections, Bacterial; Female; Fuchs' Endothelial Dystrophy; Gram-Negative Bacterial Infections; Humans; Keratoplasty, Penetrating; Methylobacteriaceae; Surgical Wound Infection; Tobramycin; Visual Acuity | 2013 |
Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Monitoring; Gentamicins; Humans; Injections; Netilmicin; Tobramycin | 2012 |
Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Biological Transport; Cell Membrane; DNA Transposable Elements; Drug Resistance, Bacterial; Gene Deletion; Gene Library; Genes, Bacterial; Genetic Complementation Test; Gentamicins; Humans; Microbial Sensitivity Tests; Mutagenesis, Insertional; Paromomycin; Pseudomonas aeruginosa; Tobramycin | 2012 |
Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tertiary Care Centers; Tobramycin | 2012 |
Streptomycin interference in Jaffe reaction - possible false positive creatinine estimation in excessive dose exposure.
Topics: Amikacin; Anti-Bacterial Agents; Chemistry, Clinical; Creatinine; Dose-Response Relationship, Drug; False Positive Reactions; Gentamicins; Humans; Kanamycin; Netilmicin; Picrates; Streptomycin; Tobramycin | 2013 |
Correlations between aminoglycoside consumption and aminoglycoside resistance in Gram-negative bacteria at a tertiary-care hospital in South Korea from 2001 to 2011.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Republic of Korea; Tertiary Care Centers; Tobramycin | 2013 |
Chemical and structural insights into the regioversatility of the aminoglycoside acetyltransferase Eis.
Topics: Acetylation; Acetyltransferases; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Catalytic Domain; Coenzyme A; Crystallography, X-Ray; Drug Resistance, Bacterial; Kanamycin; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Protein Binding; Stereoisomerism; Tobramycin | 2013 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cystic Fibrosis; Disease Progression; Drug Administration Schedule; Drug Monitoring; Gentamicins; Health Care Surveys; Humans; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tobramycin; United States | 2014 |
Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacteria; Binding Sites; Cell Survival; Drug Resistance, Bacterial; Models, Molecular; Molecular Conformation; RNA, Ribosomal, 16S; Tobramycin | 2014 |
In vivo efficacy of apramycin in murine infection models.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Interferon-gamma; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nebramycin; Neutropenia; Staphylococcal Infections; Tuberculosis, Pulmonary | 2014 |
Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital.
Topics: Amikacin; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Frequency; Genes, Bacterial; Gentamicins; Hospitals, Teaching; Humans; Iran; Kanamycin; Netilmicin; Tobramycin; Urinary Tract Infections; Uropathogenic Escherichia coli | 2014 |
"Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Delayed-Action Preparations; Drug Administration Schedule; Gentamicins; Humans; Infant, Newborn; Practice Guidelines as Topic; Tobramycin | 2014 |
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Enterobacter; Humans; Klebsiella; Microbial Sensitivity Tests; Pneumonia; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2015 |
Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.
Topics: Adult; Aerosols; Amikacin; Anti-Infective Agents; Colistin; Female; Guideline Adherence; Health Personnel; Humans; Male; Middle Aged; National Institute for Occupational Safety and Health, U.S.; Occupational Exposure; Occupational Health; Pentamidine; Respiratory Therapy; Surveys and Questionnaires; Tobramycin; United States | 2015 |
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Topics: Acinetobacter baumannii; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tobramycin | 2016 |
Nocardia asteroides Keratitis Resistant to Amikacin.
Topics: Administration, Topical; Amikacin; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Bacterial; Female; Humans; Kanamycin Resistance; Microbial Sensitivity Tests; Nocardia asteroides; Nocardia Infections; Ophthalmic Solutions; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2015 |
Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.
Topics: Achromobacter; Amikacin; Anti-Bacterial Agents; Aztreonam; Biofilms; Colistin; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Plankton; Tobramycin | 2016 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clone Cells; Drug Resistance, Bacterial; Gene Expression; Gene Frequency; Genotype; Gentamicins; Hospitals; Humans; Iran; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing; Netilmicin; Phenotype; Phylogeny; Tobramycin | 2016 |
[ThE COMPARATIVE CHARACTERISTIC OF PHENOTYPIC AND GENOTYPIC RESISTANCE TO AMINOGLYCOSIDES OF STRAINS STAPHYLOCOCCUS AUREUS ISOLATED IN TRAUMATOLOGICAI ORTHOPEDIC HOSPITAL].
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; Biotransformation; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gene Dosage; Gene Expression; Genes, Bacterial; Genome, Bacterial; Genotype; Gentamicins; Hospitals; Humans; Netilmicin; Orthopedics; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Russia; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2015 |
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin | 2016 |
Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biotransformation; Drug Resistance, Multiple, Bacterial; Enterobacter; Escherichia coli; Gene Expression; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 2016 |
Micellar Electrokinetic Chromatography of Aminoglycosides.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Cyclodextrins; Chromatography, Micellar Electrokinetic Capillary; Kanamycin; Micelles; Netilmicin; Sisomicin; Tobramycin | 2016 |
Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; Aminoglycosides; Chi-Square Distribution; Drug Resistance, Bacterial; Gentamicins; Humans; Iran; Kanamycin; Netilmicin; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tobramycin; tRNA Methyltransferases | 2017 |
Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gentamicins; Hospitals; Humans; Iran; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Sequence Analysis, DNA; Streptomycin; Tobramycin | 2017 |
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin | 2017 |
Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.
Topics: A549 Cells; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Cattle; Cell Culture Techniques; Colistin; Drug Synergism; Fetus; Gentamicins; Humans; Lung; Microbial Sensitivity Tests; Models, Biological; Oligopeptides; Pseudomonas aeruginosa; Serum; Tight Junctions; Tobramycin | 2017 |
Therapeutic Femtosecond Laser-Assisted Lamellar Keratectomy for Multidrug-Resistant Nocardia Keratitis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Corneal Surgery, Laser; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Humans; Male; Nocardia asteroides; Nocardia Infections; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Resistance to Aminoglycosides of Methicillin-Resistant Strains of Staphylococcus aureus, Originating in the Surgical and Transplantation Wards of the Warsaw Clinical Center-A Retrospective Analysis.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Gentamicins; Hospital Units; Hospitals; Humans; Kanamycin Kinase; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Netilmicin; Nucleotidyltransferases; Penicillin-Binding Proteins; Retrospective Studies; Staphylococcal Infections; Tobramycin | 2018 |
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Phages; Tobramycin | 2018 |
Characterisation of plasmid-mediated rmtB-1 in Enterobacteriaceae clinical isolates from São Paulo, Brazil.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Gentamicins; Humans; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S; Tobramycin | 2018 |
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin | 2019 |
What is the recommended amikacin dosing for cystic fibrosis patients with acute pulmonary exacerbations?
Topics: Adult; Amikacin; Aminoglycosides; Cystic Fibrosis; Humans; Monte Carlo Method; Tobramycin | 2019 |
Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults.
Topics: Adult; Alfentanil; Amikacin; Busulfan; Ceftizoxime; Child, Preschool; Humans; Infant; Injections, Intravenous; Meperidine; Metabolic Clearance Rate; Models, Biological; Oxycodone; Propofol; Sufentanil; Theophylline; Tobramycin | 2020 |
Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Hearing; Hearing Loss; Injections, Intravenous; Kidney; Kidney Diseases; Mice, Inbred C57BL; Ototoxicity; Species Specificity; Time Factors; Tobramycin | 2020 |
Evaluation of Assays to Measure Aminoglycosides in Serum: Comparison of Accuracy and Precision Based on External Quality Assessment.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Biological Assay; Gentamicins; Humans; Tobramycin | 2020 |
In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 2020 |
Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 2021 |
Thermal Stability and in Vitro Elution Kinetics of Alternative Antibiotics in Polymethylmethacrylate (PMMA) Bone Cement.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bone Cements; Drug Stability; Fosfomycin; Kinetics; Meropenem; Microbial Sensitivity Tests; Polymethyl Methacrylate; Prosthesis-Related Infections; Staphylococcus aureus; Tobramycin | 2021 |
Structural and phylogenetic analyses of resistance to next-generation aminoglycosides conferred by AAC(2') enzymes.
Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Cloning, Molecular; Crystallography, X-Ray; Drug Resistance, Bacterial; Escherichia coli; Gene Expression; Genetic Vectors; Humans; Kinetics; Models, Molecular; Netilmicin; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Providencia; Recombinant Proteins; Sisomicin; Substrate Specificity; Tobramycin | 2021 |
Identifying alternative antibiotics that elute from calcium sulfate beads for treatment of orthopedic infections.
Topics: Amikacin; Anti-Bacterial Agents; Calcium Sulfate; Cefazolin; Meropenem; Minocycline; Tobramycin; Vancomycin | 2022 |
Tobramycin Stress Induced Differential Gene Expression in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gene Expression; Microbial Sensitivity Tests; Tobramycin | 2022 |
Aminoglycosides' dosing and monitoring practices in critically ill patients in Quebec hospitals.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Gentamicins; Hospitals; Humans; Quebec; Tobramycin | 2022 |
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Gentamicins; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 2022 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
A high-efficiency scar-free genome-editing toolkit for Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Tobramycin | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
Comparing the Efficacy and Safety of Nebulized Gentamicin Plus Amikacin
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Cross-Sectional Studies; Cystic Fibrosis; Gentamicins; Humans; Pseudomonas Infections; Tobramycin | 2024 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin | 2023 |
Acinetobacter baumannii GC2 Sublineage Carrying the
Topics: Acinetobacter baumannii; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Australia; Clone Cells; Drug Resistance, Bacterial; Gentamicins; Interleukin-1 Receptor-Like 1 Protein; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 2023 |
Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Topics: Alginates; Amikacin; Anti-Bacterial Agents; Arginine; Biofilms; Ciprofloxacin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Nitrates; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |